Document:

EX-4.4

 Exhibit 4.4 
  

 
 AMENDED AND RESTATED
SHAREHOLDERS AGREEMENT 
 by and among 

Yunji Inc. 

Acceleration S Limited 

TRUSTBRIDGE PARTNERS IV, L.P. 

China Renaissance Corporation 

Eastern Bell XII Investment Limited 

CPYD Singapore Pte. Ltd. 

FASTURN OVERSEAS LIMITED 

Eastern Bell XIX Investment Limited 

China TH Capital Limited 

Fountain Sight Limited 

Shanghai Fengxian Information and Technology Development Partnership 

(LLP)
(上海丰羡信息科技发展合伙企业(有限合伙
)) 
 and 
 THE
OTHER PARTIES NAMED HEREIN 
 June 4, 2018 
  

 

 AMENDED AND RESTATED SHAREHOLDERS AGREEMENT 

This AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this “Agreement”) is entered into on June 4, 2018 by and among: 

A.    Yunji Inc., a Cayman Islands exempted company whose registered address is at the Office of Sertus
Incorporations (Cayman) Limited, Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (the
“Company”); 
 B.    Yunji Holding Limited (雲集控股有限公司), a Hong Kong company whose registered address is at Room 1907, 19/F, Lee
Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong (the “HK Co.”); 
 C.    Hangzhou
Yunchuang Sharing Network Technology Co., Ltd. (杭州云创共享网络科技有限公司), a company established under the laws of the PRC, whose registered address
is at Suite 505, 99 Xiwen Street, Xiacheng District, Hangzhou, Zhejiang Province, PRC (浙江省杭州市下城区西文街99号505室
) (the “WFOE”); 

D.    Yunji Sharing Technology Co., Ltd.
(云集共享科技有限公司), a company established under the laws of the PRC,
whose registered address is at Suite 601, No. 14, Xintiandi Business Center, Xiacheng District, Hangzhou, Zhejiang Province, PRC
(浙江省杭州市下城区新天地商务中心14
幢601室) (“Domestic Co.”); 

E.    Zhejiang Jishang Youxuan E-Commerce Co., Ltd. (浙江集商优选电子商务有限公司), a company established
under the laws of the PRC, whose registered address is at Suite 301, No. 14, Xintiandi Business Center, Xiacheng District, Hangzhou, Zhejiang Province, PRC
(浙江省杭州市下城区新天地商务中心14
幢301室) (“Operating Co.”); 
 F.    The
Persons as set forth on Schedule A-2 (each, a “Founder”, and collectively, the “Founders”); 

G.    The entities as set forth on Schedule A-3 (each a
“Founder Holdco”, and collectively, the “Founder Holdcos”); 
 H.    The
entities as set forth on Schedule B-1 (each a “Series Seed Investor”, and collectively, the “Series Seed Investors”); 

I.    The entities as set forth on Schedule B-2 (each a “Series A Investor”, and
collectively, the “Series A Investors”); 
 J.    The entities as set forth on Schedule B-3 (each a “Series B Investor” and collectively, the “Series B Investors”); and 

K.    The entities as set forth on Schedule B-4 (each a
“Series B+ Investor” and collectively, the “Series B+ Investors”, together with the Series Seed Investors, the Series A Investors and the Series B Investors, collectively, the “Investors”). 

Each of the foregoing parties is referred to herein individually as a “Party” and collectively as the
“Parties”. 

  
 1 

 RECITALS 

WHEREAS, (i) TH Capital has agreed to purchase from the Company, and the Company has agreed to sell to TH Capital, in an aggregate
of 1,108,033 Series B Preferred Shares of the Company, and (ii) the Series B+ Investors have agreed to purchase from the Company, and the Company has agreed to sell to the Series B+ Investors, in an aggregate of 21,105,395 Series B+
Preferred Shares of the Company, each on the terms and conditions set forth in the Preferred Share Purchase Agreement dated June 4, 2018 (the “Share Purchase Agreement”), by and among, the Company, the Founders, the Founder
Holdcos, the New Investors and certain other parties thereto. This Agreement is the “Shareholders Agreement” as defined in the Share Purchase Agreement. 

WHEREAS, the Company, the Founders, the Founder Holdcos, the Series Seed Investors, the Series A Investors, the Series B Investors (other than
TH Capital) and certain other parties thereto entered into certain Shareholders Agreement on February 12, 2018 (the “Prior Shareholders Agreement”) to regulate the rights and obligations among them as well as the business and
management of the Group Companies since the date thereof. 
 WHEREAS, the execution and delivery of this Agreement is a condition precedent
to the purchase by the New Investors of the Series B Preferred Shares and the Series B+ Preferred Shares (where applicable) under the Share Purchase Agreement. 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the mutual promises hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 

 

	1.	 GENERAL MATTERS. 

1.1    Definitions. Capitalized terms used herein without definition have the meanings assigned to them in Annex
A attached to this Agreement. The use of any term defined in Annex A in its uncapitalized form indicates that the words have their normal and general meaning. 
  

	2.	 INFORMATION AND INSPECTION RIGHTS. 

2.1    Information and Inspection Rights Prior to a Qualified IPO.  

(a)    Information Rights. The Company covenants and agrees that, commencing on the date of this Agreement, and for
so long as any Investor holds any Investment Securities, the Company will and will cause the Group Companies to, deliver to the Investor the following with respect to the Company and its Subsidiaries: 

(i)    annual audited consolidated financial statements within ninety (90) days after the end of each fiscal year,
audited in accordance with U.S. GAAP or other accounting principle as approved by the Preferred Majority by a reputable accounting firm approved by the Preferred Majority; 

(ii)    monthly unaudited consolidated financial statements within fifteen (15) days after the end of each month;

  
 2 

 (iii)    quarterly unaudited consolidated financial statements within
forty-five (45) days after the end of each quarter; 
 (iv)    an annual consolidated budget for the following
fiscal year within forty-five (45) days prior to the end of each fiscal year; 
 (v)    any information provided
to other Investors; and 
 (vi)    upon the request by the Investor, such other information as the Investor shall
reasonably request. 
 All financial statements to be provided to the Investors pursuant to this Section 2.1 and pursuant to any other Transaction
Document, including the Restated M&A, shall include an income statement, a balance sheet and a cash flow statement for the relevant period, and be prepared in the English language in accordance with U.S. GAAP or other accounting principle as
approved by the Preferred Majority and shall consolidate the results of operations of the Group Companies. 

(b)    Inspection Rights. The Company covenants and agrees that, commencing on the date of this Agreement, and for
so long as any Investor (together with its Affiliates) holds not less than three point five percent (3.5%) of Shares of the Company, such Investor or its appointee shall have the right of inspection, including the right to access, examine and copy
all books or accounts of each Group Company and/or any of their respective Subsidiaries, and to discuss the business, operations and conditions of each Group Company and their respective Subsidiaries with their respective directors, officers,
employees, accounts, legal counsel and investment bankers upon reasonable prior written notice and at its own cost, provided that none of the Group Companies or any of their respective Subsidiaries is obligated to provide any information which,
based on the opinion of its counsel, is reasonably deemed as trade secret or proprietary information. 
  

	3.	 REGISTRATION RIGHTS. 

3.1    Applicability of Rights. The holders of the Investment Securities shall be entitled to the following rights
with respect to any potential public offering of Ordinary Shares of the Company (or securities representing such Ordinary Shares) in the United States, and to any analogous or equivalent rights with respect to any other offering of shares in any
other jurisdiction pursuant to which the Company undertakes to publicly offer or list such securities for trading on a recognized securities exchange. 

3.2    Definitions. For purposes of this Section 3: 

(a)    Registration. The terms “register,” “registered,” and “registration” refer to
a registration effected by preparing and filing a registration statement under the Securities Act, and the declaration of effectiveness of such registration statement. 

  
 3 

 (b)    Registrable Securities. The term “Registrable
Securities” means: (1) Ordinary Shares of the Company issued or to be issued upon conversion of the Preferred Shares issued (A) under the Share Purchase Agreement and (B) pursuant to the issuance of New Securities by the
Company to the Investor pursuant to Section 4.1 hereof; (2) Ordinary Shares of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution
with respect to, or in exchange for or in replacement of, any of the foregoing; (3) any other Ordinary Share owned or hereafter acquired by the Investor, including Ordinary Shares issued in respect of the Ordinary Shares described in (1)-(2)
above upon any share split, share dividend, recapitalization or a similar event; and (4) any depositary receipts issued by an institutional depositary upon deposit of any of the foregoing. Notwithstanding the foregoing, “Registrable
Securities” shall cease to be Registrable Securities when (i) a Registration Statement covering such securities has been declared effective by the SEC and such securities have been disposed of pursuant to such effective Registration
Statement, (ii) such securities are sold under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under the Securities Act are met, (iii) such securities are otherwise transferred
and such securities may be resold without subsequent registration under the Securities Act, or (iv) such securities shall have ceased to be outstanding. 

(c)    Registrable Securities Then Outstanding. The number of shares of “Registrable Securities then
outstanding” shall mean the number of Ordinary Shares of the Company that are Registrable Securities and are then issued and outstanding or would be outstanding assuming full conversion of all Registrable Securities which are convertible
into Ordinary Shares. 
 (d)    Holder. For purposes of this Section 3, the term “Holder”
means any Person who holds Registrable Securities of record, whether such Registrable Securities were acquired directly from the Company or from another Holder in a permitted transfer, to whom the rights under this Section 3 have been duly
assigned in accordance with this Agreement; provided, however, that for purposes of this Agreement, a record holder of the Preferred Shares convertible into such Registrable Securities shall be deemed to be the Holder of such
Registrable Securities; and provided, further, that (i) the Company shall in no event be obligated to register the Preferred Shares and that (ii) Holders of Registrable Securities will not be required to convert their
Preferred Shares into Ordinary Share in order to exercise the registration rights granted hereunder, until immediately prior to the declaration of effectiveness of the registration statement for the offering to which the registration relates. 

(e)    Form S-3 and Form F-3. The
terms “Form S-3” and “Form F-3” means such respective form under the Securities Act as is in effect on the date hereof or any successor
or comparable registration form under the Securities Act subsequently adopted by the SEC, which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

3.3    Demand Registration. 

(a)    Request by Holders. If the Company shall receive, at any time after the earlier of (i) the expiration of
thirty-six (36) months after the date of the Closing, or (ii) six (6) months after a Qualified IPO, a written request from the Holders of at least twenty percent (20%) of the Registrable Securities then outstanding that the
Company files a registration statement under the Securities Act covering the registration of Registrable Securities pursuant to this Section 3.3, then the Company shall, within ten (10) Business Days after the receipt of such written
request, give a written notice of such request (the “Request Notice”) to all Holders. The Holders shall send a written notice stating the number of Registrable Securities requested to be registered and included in such registration
(the “Request Securities”) to the Company within ten (10) Business Days after receipt of the Request Notice. The Company shall thereafter use its best efforts to effect, as soon as practicable, the registration of the Request
Securities, subject only to the limitations of this Section 3.3; provided, however, that the Company shall not be obligated to effect any such registration if the Company has, within the six (6) month period preceding the
date of such request, already effected a registration under the Securities Act pursuant to this Section 3.3 or Section 3.5, or in which the Holders had an opportunity to participate pursuant to the provisions of Section 3.4, other
than a registration from which the Registrable Securities of Holders have been excluded (with respect to all or any portion of the Registrable Securities the Holders requested be included in such registration) pursuant to the provisions of
Section 3.4(a). 

  
 4 

 (b)    Underwriting. If the Holders initiating the registration
request under this Section 3.3 (the “Initiating Holders”) intend to distribute the Registrable Securities covered by their request by means of an underwriting, then they shall so advise the Company as a part of their request
made pursuant to this Section 3.3 and the Company shall include such information in the Request Notice referred to in Section 3.3(a). In the event of an underwritten offering, the right of any Holder to include its Registrable Securities
in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of
the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or
underwriters selected for such underwriting by the Holders of a majority of the Registrable Securities being registered and reasonably acceptable to the Company. Notwithstanding any other provision of this Section 3.3, if the underwriter(s)
advise(s) the Company in writing that marketing factors require a limitation of the number of securities to be underwritten, then the Company shall so advise all Holders of Registrable Securities which would otherwise be registered and underwritten
pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be reduced as required by the underwriter(s) and allocated among the Holders of Registrable Securities on a
pro-rata basis according to the number of Registrable Securities then outstanding held by each Holder requesting registration (including the Initiating Holders); provided, however, that the
number of shares of Registrable Securities to be included in such underwriting and registration shall not be reduced (x) by more than seventy-five percent (75%) and (y) unless all other securities are first entirely excluded from the
underwriting and registration including all shares that are not Registrable Securities and are held by any other Person, including any Person who is an employee, officer or director of the Company or any Subsidiary of the Company. Further, if, as a
result of such underwriter cutback, the Holders cannot include in the IPO all of the Registrable Securities that they have requested to be included therein, then such Registration shall not be deemed to constitute one of the three (3) demand
Registrations to which the Holders are entitled pursuant to this Section 3. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by delivering a written notice to the Company and the
underwriter(s), delivered at least ten (10) Business Days prior to the effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration.
For any Holder that is a partnership, the Holder and the partners and retired partners of such Holder, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing Persons, and
for any Holder that is a corporation, the Holder and all corporations that are affiliates of such Holder, shall be deemed to be a single “Holder,” and any pro-rata reduction with respect to such
“Holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such “Holder,” as defined herein. 

  
 5 

 (c)    Maximum Number of Demand Registrations. The Company shall
have no obligation to effect more than three (3) registrations pursuant to this Section 3.3. 

(d)    Deferral. Notwithstanding the foregoing, if the Company shall furnish to the Holders requesting the filing
of a registration statement pursuant to this Section 3.3, a certificate signed by the president or chief executive officer of the Company stating that in the good faith judgment of the Board, it would be materially detrimental to the Company
and its shareholders for such registration statement to be filed, then the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided,
however, that the Company may not utilize this right more than once in any twelve (12) month period; provided further that during such ninety (90) day period, the Company shall not file any registration statement pertaining
to the public offering of any securities of the Company. 
 (e)    Expenses. The Company shall pay all expenses
(excluding only underwriting discounts and commissions relating to the Registrable Securities sold by the Holders) incurred in connection with any registration pursuant to this Section 3.3, including all U.S. federal, “blue sky” and
all foreign registration, filing and qualification fees, printer’s and accounting fees, the fees and expenses (including disbursements) of outside counsels for the Holders and any fee charged by any depositary bank, transfer agent or share
registrar. Each Holder participating in a registration pursuant to this Section 3.3 shall bear such Holder’s proportionate share (based on the total number of shares of Registrable Securities sold in such registration other than for the
account of the Company) of all discounts and commissions relating to the Registrable Securities sold by the Holders. Notwithstanding the foregoing, the Company shall not be required to pay any expense of any registration proceeding begun pursuant to
this Section 3.3 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered, unless the Holders of a majority of the Registrable Securities then outstanding
agree that such registration constitutes the use by the Holders of one (1) demand registration pursuant to this Section 3.3 (in which case such registration shall also constitute the use by all Holders of Registrable Securities of one
(l) such demand registration); provided further, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company not known to the
Holders at the time of their request for such registration and have withdrawn their request for registration with reasonable promptness after learning of such material adverse change, or if the registration proceeding is terminated for any reason
not specifically covered by this Section 3.3(e), then the Company shall be required to pay all of such expenses and such registration shall not constitute the use of a demand registration pursuant to this Section 3.3. 

3.4    Piggyback Registrations. The Company shall notify all Holders of Registrable Securities in writing at least
thirty (30) days prior to filing of any registration statement under the Securities Act for purposes of effecting a public offering of securities of the Company (including registration statements relating to secondary offerings of securities of
the Company, but excluding registration statements relating to any registration under Section 3.3 or Section 3.5 of this Agreement or to any employee benefit plan or a corporate reorganization) and will afford each such Holder an
opportunity to include in such registration statement all or any part of the Registrable Securities then held by such Holder. Each Holder desiring to include in any such registration statement all or any part of the Registrable Securities held by
such Holder shall within ten (10) Business Days after receipt of the above-described notice from the Company, so notify the Company in writing, and in such notice shall inform the Company of the number of Registrable Securities such Holder
wishes to include in such registration statement. If a Holder decides not to include all of its Registrable Securities in any registration statement thereafter filed by the Company, such Holder shall nevertheless continue to have the right to
include any Registrable Securities in any subsequent registration statement or registration statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein. 

  
 6 

 (a)    Underwriting. If a registration statement under which the
Company gives notice under this Section 3.4 is for an underwritten offering, then the Company shall so advise the Holders of Registrable Securities. In such event, the right of any such Holder’s Registrable Securities to be included in a
registration pursuant to this Section 3.4 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All
Holders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected by the Company for such underwriting.
Notwithstanding any other provision of this Agreement, if the managing underwriter(s) determine(s) in good faith that marketing factors require a limitation of the number of shares to be underwritten, then the managing underwriter(s) may exclude
shares from the registration and the underwriting, and the number of shares that may be included in the registration and the underwriting shall be allocated, first to the Company, and second, to each of the Holders requesting inclusion
of their Registrable Securities in such registration statement on a pro-rata basis based on the total number of Registrable Securities then held by each such Holder; provided, however, that the
right of the underwriter(s) to exclude shares (including Registrable Securities) from the registration and underwriting as described above shall be restricted so that (i) the number of Registrable Securities included in any such registration is
not reduced below twenty-five percent (25%) of the aggregate number of Registrable Securities for which inclusion has been requested, even if this will cause the Company to reduce the number of shares it wishes to offer; and (ii) all shares
that are not Registrable Securities and are held by any other Person, including any Person who is an employee, officer or director of the Company or any Subsidiary of the Company shall first be excluded from such registration and underwriting before
any Registrable Securities are so excluded. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by delivering a written notice to the Company and the underwriter(s) at least ten
(10) Business Days prior to the effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration. For any Holder that is a partnership,
the Holder and the partners and retired partners of such Holder, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing Persons, and for any Holder that is a corporation,
the Holder and all corporations that are affiliates of such Holder, shall be deemed to be a single “Holder,” and any pro-rata reduction with respect to such “Holder” shall be based upon the
aggregate amount of shares carrying registration rights owned by all entities and individuals included in such “Holder,” as defined in this sentence. 

(b)    Expenses. The Company shall pay all expenses (excluding only underwriting and brokers’ discounts and
commissions relating to shares sold by the Holders) incurred in connection with a registration pursuant to this Section 3.4, including all U.S. federal, “blue sky” and all foreign registration, filing and qualification fees,
printers’ and accounting fees, the fees and expenses (including disbursements) of outside counsels for the Holders and any fee charged by any depositary bank, transfer agent or share registrar. For the avoidance of doubt, the Company shall pay
all expenses incurred in connection with a registration pursuant to this Section 3.4 notwithstanding the cancellation or delay of the registration proceeding for any reason. 

  
 7 

 (c)    Not Demand Registration. Registration pursuant to this
Section 3.4 shall not be deemed to be a demand registration as described in Section 3.3 above. Except as otherwise provided herein, there shall be no limit on the number of times the Holders may request registration of Registrable
Securities under this Section 3.4. 
 3.5    Form S-3 or Form F-3 Registration. After its initial public offering, the Company shall use its best efforts to qualify for registration on Form S-3 or Form
F-3 or any comparable or successor form promptly and to maintain such qualification thereafter. If the Company is qualified to use Form S-3 or Form F-3, any Holder or Holders shall have a right to request in writing that the Company effect a registration on either Form S-3 or Form
F-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, and upon receipt of each such request, the Company shall perform the
tasks set out in paragraphs (a) and (b) below: 
 (a)    Notice. Promptly give written notice of the
proposed registration and the Holder’s or Holders’ request therefor, and any related qualification or compliance, to all other Holders of Registrable Securities; and 

(b)    Registration. As soon as practicable, effect such registration and all such qualifications and compliances
as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders or Holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable
Securities of any other Holder or Holders joining in such request as are specified in a written request given within twenty (20) days after the date on which the Company provides the notice contemplated by Section 3.5(a); provided,
however, that the Company shall not be obligated to effect any such registration, qualification or compliance pursuant to this Section 3.5: 

(i)    if Form S-3 or Form F-3 becomes
unavailable for such offering by the Holders; 
 (ii)    if the Holders, together with the holders of any other
securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price of less than US$1,000,000 to the public; or 

(iii)    if the Company has, within the six (6) month period preceding the date of such request, already effected a
registration under the Securities Act other than a registration from which the Registrable Securities of Holders have been excluded (with respect to all or any portion of the Registrable Securities the Holders requested be included in such
registration) pursuant to the provisions of Section 3.4(a). 
 (c)    Expenses. The Company shall pay all
expenses (excluding only underwriting or brokers’ discounts and commissions relating to shares sold by the Holders) incurred in connection with each registration requested pursuant to this Section 3.5, including all U.S. federal,
“blue sky” and all foreign registration, filing and qualification fees, printers’ and accounting fees, the fees and expenses (including disbursements) of outside counsels for the Holders and any fee charged by any depositary bank,
transfer agent or share registrar. For the avoidance of doubt, the Company shall pay all expenses incurred in connection with a registration pursuant to this Section 3.5 notwithstanding the cancellation or delay of the registration proceeding
for any reason. 

  
 8 

 (d)    Maximum Frequency. Except as otherwise provided herein,
there shall be no limit on the number of times the Holders may request registration of Registrable Securities under this Section 3.5. 

(e)    Deferral. Notwithstanding the foregoing, if the Company shall furnish to Holders requesting the filing of a
registration statement pursuant to this Section 3.5, a certificate signed by the president or chief executive officer of the Company stating that in the good faith judgment of the Board, it would be materially detrimental to the Company and its
shareholders for such Form S-3 or Form F-3 registration statement to be filed, then the Company shall have the right to defer such filing for a period of not more than
ninety (90) days after receipt of the request of the initiating Holders; provided, however, that the Company may not utilize this right more than once in any twelve (12) month period; provided further that during such
ninety (90) day period, the Company shall not file any registration statement pertaining to the public offering of any securities of the Company. 

(f)    Not Demand Registration. Form S-3 or Form F-3 registrations shall not be deemed to be demand registrations as described in Section 3.3 above. 

(g)    Underwriting. If the requested registration under this Section 3 is for an underwritten offering, the
provisions of Section 3.3(b) shall apply. 
 If the Company fails to perform any of the Company’s obligations set forth above in this
Section 3.5 relating to a demand registration made pursuant to Section 3.3, such registration shall not constitute the use of a demand registration under Section 3.3. 

3.6    Obligations of the Company. Whenever required to effect the registration of any Registrable Securities under
this Agreement, the Company shall, as soon as practicable: 
 (a)    Registration Statement. Prepare and file
with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to become effective, and keep any such registration statement effective for a period of one (1) year
or until the Holder or Holders have completed the distribution described in the registration statement relating thereto, whichever is earlier; 

(b)    Amendments and Supplements. Prepare and file with the SEC such amendments and supplements to such
registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities covered by such
registration statement; 
 (c)    Prospectuses. Furnish to the Holders such number of copies of a prospectus,
including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of the Registrable Securities owned by them that are
included in such registration; 
 (d)    Blue Sky. Use its best efforts to register and qualify the securities
covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition
thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions; 

  
 9 

 (e)    Deposit Agreement. If the registration relates to an
offering of depositary shares or other securities representing Ordinary Shares deposited pursuant to a deposit agreement or similar facility, cause the depositary under such agreement or facility to accept for deposit under such agreement or
facility all Registrable Securities requested by each Holder to be included in such registration in accordance with this Section 3. 

(f)    Underwriting. In the event of any underwritten public offering, enter into and perform its obligations under
an underwriting agreement in usual and customary form, with the managing underwriter(s) of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement; 

(g)    Notification. Notify each Holder of Registrable Securities covered by such registration statement at any
time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement
of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; 

(h)    Opinions and Comfort Letter. Furnish, at the request of any Holder requesting registration of Registrable
Securities, on the date that such Registrable Securities are delivered to the underwriter(s) for sale, if such Registrable Securities are being sold through underwriters, or, if such Registrable Securities are not being sold through underwriters, on
the date that the registration statement with respect to such Registrable Securities becomes effective, (i) opinions, each dated as of such date, of the counsels representing the Company for the purposes of such registration, in form and
substance as is customarily given to underwriters in an underwritten public offering and reasonably satisfactory to Holders representing a majority of the Registrable Securities requested to be registered, addressed to the underwriters, if any, and
to the Holders requesting registration of Registrable Securities and (ii) a “comfort letter” dated as of such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by
independent certified public accountants to underwriters in an underwritten public offering and reasonably satisfactory to Holders representing a majority of the Registrable Securities requested to be registered, addressed to the underwriters, if
any, and to the Holders requesting registration of Registrable Securities. 
 3.7    Furnish Information. It
shall be a condition precedent to the obligations of the Company to take any action pursuant to Sections 3.3, 3.4 or 3.5 that the Holders shall furnish to the Company information regarding such Holders, the Registrable Securities held by them and
the intended method of disposition of such Registrable Securities as shall reasonably be required to timely effect the Registration of their Registrable Securities. 

  
 10 

 3.8    Indemnification. In the event any Registrable Securities
are included in a registration statement under Sections 3.3, 3.4 or 3.5: 
 (a)    By the Company. To the extent
permitted by law, the Company shall indemnify and hold harmless each Holder and its Affiliates, partners, officers, directors, employee, legal counsel, agent, any underwriter (as determined in the Securities Act) for such Holder and each Person, if
any, who Controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange
Act or other applicable law, insofar as such losses, claims, damages, or liabilities or actions in respect thereof arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”):

 (i)    any untrue statement or alleged untrue statement of a material fact contained in such registration statement,
including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; 

(ii)    the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or 
 (iii)    any violation or alleged violation of the Securities Act,
the Exchange Act, any federal or state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or other applicable law in connection with the offering covered by such registration statement; 

and the Company shall reimburse each such Holder and its Affiliates, partners, officers, directors, employees, legal counsel, agents, underwriters or
controlling Person for any legal or other expenses reasonably incurred by them, in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity contained in
this Section 3.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld,
conditioned or delayed, nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with
written information furnished expressly for use in connection with such registration by such Holder, underwriter or controlling Person of such Holder. 

(b)    By Selling Shareholders. To the extent permitted by law, each selling Holder, on a several and not joint
basis, will indemnify and hold harmless the Company, each of its directors, each of its officers who have signed the registration statement, each Person, if any, who Controls the Company, any underwriter and any other Holder selling securities under
such registration statement or any of such other Holder’s partners, directors, officers, legal counsel or any Person who Controls such Holder within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages or
liabilities (joint or several) to which the Company or any such director, officer, legal counsel, controlling Person, underwriter or other such Holder, partner or director, officer or controlling Person of such other Holder may become subject under
the Securities Act, the Exchange Act or other applicable law, insofar as such losses, claims, damages or liabilities or actions in respect thereto arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that
such Violation occurs in the Company’s reasonable reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will reimburse any legal or other
expenses reasonably incurred by the Company or any such director, officer, controlling Person, underwriter or other Holder, partner, officer, director or controlling Person of such other Holder in connection with investigating or defending any such
loss, claim, damage, liability or action: provided, however, that the indemnity contained in this Section 3.8(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement
is effected without the consent of the Holder, which consent shall not be unreasonably withheld; and provided further that the total amounts payable in indemnity by a Holder under this Section 3.8(b) plus any amount under
Section 3.8(e) in respect of any Violation shall not exceed the net proceeds received by such Holder in the registered offering out of which such Violation arises. 

  
 11 

 (c)    Notice. Promptly after receipt by an indemnified party
under this Section 3.8 of notice of the commencement of any action, including any governmental action, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 3.8, deliver
to the indemnifying party a written notice of the commencement thereof (a “Claim Notice”) and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any
other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the Parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and
expenses to be paid by the indemnifying party, (i) during the period from the delivery of a Claim Notice until retention of counsel by the indemnifying party; and (ii) if representation of such indemnified party by the counsel retained by
the indemnifying party would be inappropriate due to actual or potential conflict of interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver a written notice to the
indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of liability to the indemnified party under this Section 3.8 to the extent the indemnifying party is prejudiced as a result
thereof, but the omission to deliver a written notice to the indemnified party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 3.8. 

(d)    Defect Eliminated in Final Prospectus. The foregoing indemnity of the Company and Holders are subject to the
condition that, insofar as they relate to any Violation made in a preliminary prospectus but eliminated or remedied in the amended prospectus on file with the SEC at the time the registration statement in question becomes effective or the amended
prospectus filed with the SEC pursuant to SEC Rule 424(b) (the “Final Prospectus”), such indemnity shall not inure to the benefit of any Person if a copy of the Final Prospectus was timely furnished to the indemnified party and was
not furnished to the Person asserting the loss, liability, claim or damage at or prior to the time such action is required by the Securities Act. 

(e)    Contribution. In order to provide for just and equitable contribution to joint liability under the
Securities Act in any case in which either (i) any Holder exercising rights under this Agreement, or any controlling Person of any such Holder, makes a claim for indemnification pursuant to this Section 3.8 but it is judicially determined
(by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that
this Section 3.8 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any such selling Holder or any such controlling Person in circumstances for which indemnification is
provided under this Section 3.8; then, and in each such case, the Company and such Holder will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in such proportion
so that such Holder is responsible for the portion represented by the percentage that the public offering price of its Registrable Securities offered by and sold under the registration statement bears to the public offering price of all securities
offered by and sold under such registration statement, and the Company and other selling Holders are responsible for the remaining portion; provided, however, that, in any such case: (A) no such Holder will be required to
contribute any amount in excess of the net proceeds received by such Holder pursuant to such registration statement; and (B) no Person or entity guilty of fraudulent misrepresentation as defined in Section 11(f) of the Securities Act will
be entitled to contribution from any Person or entity who was not guilty of such fraudulent misrepresentation. 

  
 12 

 (f)    Survival. The obligations of the Company and Holders under
this Section 3.8 shall survive for six (6) years after the completion of any offering of Registrable Securities in a registration statement, regardless of the expiration of any statutes of limitation or extensions of such statutes. 

3.9    Rule 144 Reporting. With a view to making available to the Holders the benefits of certain rules and
regulations of the SEC which may permit the sale of the Registrable Securities to the public without registration, the Company agrees to: 

(a)    Make and keep public information available, as those terms are understood and defined in Rule 144 or any similar or
analogous rule promulgated under the Securities Act, at all times after the effective date of the first registration filed by the Company for an offering of its securities to the general public; 

(b)    File with the SEC, in a timely manner, all reports and other documents required of the Company under the Securities
Act or the Exchange Act, at all times after the effective date of the first registration under the Securities Act filed by the Company; 

(c)    So long as a Holder owns any Registrable Securities, furnish to such Holder forthwith upon request, (i) a
written statement by the Company as to its compliance with the reporting requirements of said Rule 144 of the Securities Act, and of the Exchange Act (at any time after it has become subject to such reporting requirements, (ii) a copy of the
most recent annual, interim, quarterly or other report of the Company and, (iii) such other reports and documents as a Holder may reasonably request availing itself of any rule or regulation of the SEC allowing it to sell any such securities
without registration. 
 3.10    Termination of the Company’s Obligations. Notwithstanding the
foregoing, the Company shall have no obligations pursuant to Sections 3.3, 3.4 or 3.5 with respect to any Registrable Securities proposed to be sold by a Holder in a registered public offering (i) two (2) years after the consummation of a
Qualified IPO, or (ii), if, in the opinion of counsel to the Company, all such Registrable Securities proposed to be sold by a Holder may then be sold under Rule 144 in one transaction without exceeding the volume limitations thereunder. 

3.11    No Registration Rights to Third Parties. Without the prior written consent of the Holders of more than
fifty percent (50%) of the Registrable Securities then outstanding, the Company covenants and agrees that it shall not grant, or cause or permit to be created, for the benefit of any Person or entity any registration rights of any kind, whether
similar to the demand, “piggyback” or Form S-3 or Form F-3 registration rights described in this Section 3, or otherwise, relating to any shares or other
securities of the Company, other than rights that are subordinate to the rights of the Holders hereunder. 

  
 13 

 3.12    “Market
Stand-Off” Agreement. Each Holder hereby agrees that, if and to the extent requested by the lead underwriter of securities of the Company in connection with a registration relating to a specific
proposed public offering (other than a registration on Form S-8 or a related or successor form relating solely to an employee benefit plan or a registration on Form S-4
or a related or successor form relating solely to a transaction under SEC Rule 145), such Holder will, subject to the following conditions, enter into a lock-up or standoff agreement in customary form (subject
to the following conditions) under which such Holder agrees not to sell or otherwise transfer or dispose of any Registrable Securities or other shares of the Company owned by such Holder as of the date of such registration for up to one hundred
eighty (180) days following the effective date of the related registration statement. The obligations of each Holder under this Section 3.12 are subject to the following conditions: (i) the lockup or standoff agreement applies only to
the first registration statement of the Company which covers securities to be sold on its behalf to the public in an underwritten offering, but not to Registrable Securities actually sold pursuant to such registration statement; (ii) such
Holder is satisfied that all directors, officers, and holders of 1% or more of any class of securities of the Company are bound by substantially identical restrictions; (iii) the lockup or standoff agreement provides that if any securities of
the Company are to be excluded or released in whole or part from such restrictions, the underwriter shall so notify each Holder within three (3) days and each Holder shall be excluded or released, in proportionate amounts to the extent of the
exclusion or release with respect to any other holder of Company’s securities, including any director, officer, or holder of 1% or more of any class of securities of the Company subject to such restrictions; and (iv) the lockup or standoff
agreement by its terms permits transfers of Registrable Securities by any Holder to any Affiliate of such Holder during the restricted period, provided that such Affiliate executes a lock-up or standoff
agreement substantively identical to that signed by the transferring Holder. The lock-up or standoff agreement shall expire no later than ninety (90) days after execution by the Holder if no underwritten
public offering has occurred by the date of such execution. The Company may impose a stop-transfer restriction with respect to Registrable Securities that are that are subject to any such lockup or standoff agreement, but shall remove such
restriction immediately upon the expiration or termination of such lockup or standoff agreement. 
 3.13    Public
Offering Rights (Non-U.S. Offerings). If shares of the Company are offered in an underwritten public offering (whether or not a Qualified IPO) outside of the United States for the account of any Ordinary
Shareholder or other shareholders, each Holder shall have the right to include a pro-rata number of shares (based on the number of shares (on an as-converted basis) then
held by such Holder and all other shareholders of the Company selling in such offering) in such offering on terms and conditions no less favorable to the Holders than to any other selling shareholder. 

3.14    Re-sale Rights. The Company shall use its best efforts to assist
each Holder in the sale or disposition of its Registrable Securities after a Qualified IPO, including the prompt delivery of applicable instruction letters by the Company and legal opinions from the Company’s counsels in forms reasonably
satisfactory to the Holder’s counsel. In the event the Company has depositary receipts listed or traded on any stock exchange or inter-dealer quotation system, the Company shall pay all costs and fees related to such depositary facility,
including conversion fees and maintenance fees for Registrable Securities held by the Holders. 
  

	4.	 RIGHT OF PARTICIPATION. 

4.1    With Respect to Issuance of New Securities:  

(a)    General. Each holder of Shares (the “Participation Rights Holders”, and each a
“Participation Rights Holder”) shall have a right of first refusal to purchase such a Pro Rata Share of all or any part of the New Securities that the Company may from time to time issue after the date of this Agreement (the
“Right of Participation”). Each Participation Rights Holder shall be entitled to apportion its Right of Participation hereby granted to it among itself and its Affiliates in such proportions as it deems appropriate. 

(b)    Pro Rata Share. A Participation Rights Holder’s “Pro Rata Share” is the ratio of
(a) the number of Ordinary Shares (assuming conversion of all convertible securities) then held by such Participation Rights Holder, to (b) the total number of Ordinary Shares (assuming conversion of all convertible securities) then
outstanding immediately prior to the issuance of New Securities giving rise to the Right of Participation. 

  
 14 

 (c)    New Securities. “New Securities” shall
mean any Preferred Shares, Ordinary Shares or other voting shares of the Company, whether now authorized or not, and rights, options or warrants to purchase such Preferred Shares, Ordinary Shares and securities of any type whatsoever that are, or
may become, convertible or exchangeable into such Preferred Shares, Ordinary Shares or other voting shares, provided, however, that the term “New Securities” shall not include: 

(i)    any outstanding securities convertible into Preferred Shares as of the date hereof, or any Ordinary Shares issued
upon conversion of the Preferred Shares authorized; 
 (ii)    any securities issued in connection with any share
split, share dividend or any subdivision, combination, recapitalization or other similar event in which all Participation Rights Holders are entitled to participate on a pro rata basis; 

(iii)    Ordinary Shares (and/or options or warrants therefor) issued or issuable to officers, directors, employees and
consultants of the Group Companies pursuant to any equity plan or incentive arrangement approved or to be approved pursuant to the Restated M&A; 

(iv)    any securities issued or issuable upon the exercise, conversion or exchange of any option, warrant or other right
to acquire any security which is issued and outstanding as of the date hereof; 
 (v)    those issued as a dividend or
distribution on Preferred Shares or any event for which adjustment is made; 
 (vi)    any securities issued pursuant
to the acquisition of another corporation or entity by the Company by consolidation, merger, purchase of assets, or other reorganization in which the Company acquires, in a single transaction or series of related transactions, a majority of the
assets, voting power or equity ownership of such other corporation or entity, as duly approved pursuant to the the Restated M&A; 

(vii)    any securities offered in an underwritten registered public offering by the Company, as duly approved pursuant
to the Restated M&A. 
 (d)    Procedures. 

(i)    First Participation Notice. In the event that the Company proposes to undertake an issuance of New
Securities in a single transaction or a series of related transactions, it shall give to each Participation Rights Holder a written notice of its intention to issue New Securities (the “First Participation Notice”), describing the
amount, the type and the price of New Securities and the general terms upon which the Company proposes to issue such New Securities. Each Participation Rights Holder shall be entitled to purchase such Participation Rights Holder’s Pro Rata
Share of such New Securities at the price and upon the terms and conditions specified in the First Participation Notice by giving a written notice to the Company and stating therein the number of New Securities to be purchased (such number shall not
exceed such Participation Rights Holder’s Pro Rata Share) within thirty (30) Business Days from the date of such First Participation Notice. If any Participation Rights Holder fails to send such written notice within the prescribed time
period or declines to exercise fully its Right of Participation, then the right of such Participation Rights Holder to purchase its Pro Rata Share hereunder shall be forfeited. 

  
 15 

 (ii)    Second Participation Notice. If any Participation Rights
Holder fails or declines to exercise fully its Right of Participation in accordance with subsection (d)(i) above, the Company shall promptly give a written notice (the “Second Participation Notice”) to the Participation Rights
Holders who agreed to fully exercise their Right of Participation (the “Rights Participants”) in accordance with subsection (d)(i) above. Each Rights Participant shall have five (5) days from the date of the Second
Participation Notice (the “Second Participation Period”) to notify the Company of its desire to purchase more than its Pro Rata Share of the New Securities, stating the number of the additional New Securities it proposes to
purchase. Such notice may be made by telephone if followed by a written confirmation within two (2) Business Days from the date of verbal notice. If as a result thereof, such oversubscription exceeds the total number of the remaining New
Securities available for purchase, the oversubscribing Rights Participants will be cut back by the Company with respect to their oversubscriptions to that number of remaining New Securities equal to the product obtained by multiplying (i) the
number of the remaining New Securities available for subscription by (ii) a fraction the numerator of which is the number of Ordinary Shares (assuming conversion of all convertible securities) held by each oversubscribing Rights Participant and
the denominator of which is the total number of Ordinary Shares (assuming conversion of all convertible securities) held by all the oversubscribing Rights Participants. Each oversubscribing Rights Participant shall be obligated to purchase such
number of additional New Securities as determined by the Company pursuant to this subsection (d)(ii) and the Company shall so notify the Rights Participants within fifteen (15) days from the date of the Second Participation Notice. 

(e)    Failure to Exercise. (i) In the event the Participation Rights Holders do not exercise the Right of
Participation with respect to all New Securities described in the First Participation Notice, after thirty (30) Busienss Days following the date of the First Participation Notice, or (ii) upon the expiration of the Second Participation
Period, the Company shall have a period of ninety (90) days thereafter to sell the New Securities described in the First Participation Notice (with respect to which the Right of Participation was not fully exercised) at the same price and upon
the same non-price terms specified in the First Participation Notice. In the event that the Company has not issued and sold such New Securities within such prescribed period, then the Company shall not
thereafter issue or sell any New Securities without first offering such New Securities to the Participation Rights Holders pursuant to this Section 4. 

4.2    With Respect to Shares Owned by the Ordinary Shareholders: 

(a)    Restriction on Transfers. Subject to Section 10.1, each Founder, Founder Holdco or Ordinary Shareholder
may not sell, transfer, pledge, hypothecate, encumber or otherwise dispose of his/its Shares to any Person, whether directly or indirectly, except with the prior written consent of the Preferred Majority and in compliance with this Section 4.2
and Section 5. 
 (b)    Notice of Sale. If any Founder, Founder Holdco or Ordinary Shareholder (each a
“Selling Shareholder”) proposes to sell or transfer, directly or indirectly, any of its Shares (the “Transfer Shares”), except for any transfer carried out pursuant to Section 9.1 hereof, then the Selling
Shareholder shall promptly give a written notice (the “Transfer Notice”) to the Company and to each holder of the Preferred Shares (the “Non-Selling Shareholder”), which
Transfer Notice shall include (i) the number of Transfer Shares to be sold or transferred and the nature of such sale or transfer, (ii) the identity (identities) (including name(s) and address(es)) of the prospective transferee(s), and
(iii) the consideration and the material terms and conditions upon which the proposed sale or transfer is to be made. The Transfer Notice shall certify that the Selling Shareholder has received a firm offer from the prospective transferee(s)
and in good faith believes a binding agreement for the sale or transfer is obtainable on the terms set forth in the Transfer Notice. The Transfer Notice shall also include a copy of any written proposal, term sheet or letter of intent or other
agreement relating to the proposed transfer. 

  
 16 

 (c)    Notice of Purchase. Each
Non-Selling Shareholder shall be entitled to purchase all or any part of such Non-Selling Shareholder’s pro rata share of the Transfer Shares at the price and upon
the terms and conditions specified in the Transfer Notice by giving a written notice to the Selling Shareholder within ten (10) Business Days after the date of the Transfer Notice (the “First Refusal Period”) stating therein
the number of Transfer Shares to be purchased. If a Non-Selling Shareholder exercises such right and notifies the Selling Shareholder of the number of Transfer Shares to be purchased, then such Non-Selling Shareholder shall complete the purchase of the Transfer Shares on the same terms and conditions as those set out in the Transfer Notice. A failure by a Non-Selling
Shareholder to respond within the First Refusal Period shall constitute a decision by such Non-Selling Shareholder not to exercise its right to purchase such Transfer Shares. For purposes of this clause (c),
each Non-Selling Shareholder’s pro rata share of the Transfer Shares shall be equal to the number of Transfer Shares, multiplied by a fraction, the numerator of which shall be the number of Ordinary
Shares (on an as-converted basis) held by such Non-Selling Shareholder on the date of the Transfer Notice and the denominator of which shall be the total number of
Ordinary Shares (on an as-converted basis) held on the date of the Transfer Notice by all Non-Selling Shareholders which may exercise their right of first refusal under
this clause (c) on the date of the Transfer Notice. 
 (d)    Second Transfer Notice;
Over-Allotment. To the extent that any Non-Selling Shareholder does not exercise its right of first refusal to the full extent to purchase such Non-Selling
Shareholder’s pro rata share of the Transfer Shares, the Selling Shareholder shall deliver written notice thereof (the “Second Transfer Notice”), within two (2) days after the expiration of the First Refusal
Period, to each Non-Selling Shareholder that elected to the full extent to purchase such Non-Selling Shareholder’s pro rata share of the Transfer Shares (the
“Exercising Holder”). Each Exercising Holder shall have five (5) days from the date of the Second Transfer Notice (the “Second Refusal Period”) to notify the Selling Shareholder of its desire to
purchase more than its pro rata share of the Transfer Shares, stating the number of the additional Transfer Shares it proposes to purchase. Such notice may be made by telephone if followed by a written confirmation within two (2) Business Days
from the date of verbal notice. If as a result thereof, such over-allotment exceeds the total number of the remaining Transfer Shares available for purchase, the overpurchasing Exercising Holders will be cut back or limited by the Selling
Shareholder with respect to their over-allotment to that number of remaining Transfer Shares equal to the lesser of (a) the number of the additional Transfer Shares it proposes to purchase; (b) the product obtained by multiplying
(i) the number of the remaining Transfer Shares available for purchase by (ii) a fraction the numerator of which is the number of Ordinary Shares (on an as-converted basis) held by each
overpurchasing Exercising Holder and the denominator of which is the total number of Ordinary Shares (on an as-converted basis) held by all the overpurchasing Exercising Holders. Each overpurchasing Exercising
Holder shall be obligated to purchase such number of additional Transfer Shares as determined by the Selling Shareholder pursuant to this subsection (d) and the Selling Shareholder shall so notify such Exercising Holders within ten
(10) days from the date of the Second Transfer Notice. 

  
 17 

 (e)    Notice of Expiry. Within three (3) days after the
expiry of the Second Refusal Period, the Selling Shareholder shall issue a written notice (the “ROFR Expiry Notice”) to each Non-Selling Shareholder, certifying either (i) all the
Transfer Shares have been agreed to be purchased by the Non-Selling Shareholders pursuant to Section 4.2, or (ii) the Non-Selling Shareholders do not
exercise their rights of first refusal as to all the Transfer Shares pursuant to Section 4.2, in which circumstance, the ROFR Expiry Notice shall further specify the “Pro Rata Co-Sale
Share” of each Non-Selling Shareholder who does not exercise its respective rights of first refusal as to any Transfer Share pursuant to Section 4.2 (each a “Co-Sale Right Holder”). The transfer of any remaining Transfer Shares shall be subject to Section 5 below. 
  

	5.	 INVESTOR’S CO-SALE RIGHT.

 5.1    Co-Sale Right. To the extent any Non-Selling Shareholder does not exercise its respective rights of first refusal as to any Transfer Share pursuant to Section 4.2, each Co-Sale Right Holder shall have
the right, exercisable upon delivery of a written notice to the Selling Shareholder, with a copy to the Company, within ten (10) days after the date of the ROFR Expiry Notice, to participate in the sale of any Transfer Shares to the extent of
such Co-Sale Right Holder’s Pro Rata Co-Sale Share at the same price and upon the same terms and conditions indicated in the Transfer Notice. A failure by any Co-Sale Right Holder to respond within such prescribed period shall constitute a decision by such Co-Sale Right Holder not to exercise its right of co-sale as provided herein. To the extent one (1) or more of Co-Sale Right Holders exercise such right of co-sale in accordance
with the terms and conditions set forth below, the number of Transfer Shares that the Selling Shareholder may sell in the transaction shall be correspondingly reduced. The foregoing co-sale right of each Co-Sale Right Holder shall be subject to the following terms and conditions: 

(a)    each Co-Sale Right Holder may sell all or any part of its Pro Rata Share of
the remaining Transfer Shares. A Co-Sale Right Holder’s “Pro Rata Co-Sale Share” of the remaining Transfer Shares shall mean that number of
Ordinary Shares (or that number of Preferred Shares which, if converted at the current conversion ratio, would equal that number of Ordinary Shares) which equals the specified quantity of remaining Transfer Shares multiplied by a fraction equal to
(i) the total number of Ordinary Shares (on an as-converted basis) then held by such Co-Sale Right Holder on the date of the ROFR Expiry Notice , divided by
(ii) the total number of Ordinary Shares held by the Selling Shareholder plus the total number of Ordinary Shares then held by all the Co-Sale Right Holders on the date of the ROFR Expiry Notice, on an as-converted basis. As used in this definition, the phrase “on an as-converted basis” shall mean assuming conversion of all Preferred Shares but not assuming
exercise or conversion of any other outstanding option, warrants, or other convertible securities. 
 (b)    each Co-Sale Right Holder shall effect its participation in the sale by promptly delivering to the Selling Shareholder, with a copy to the Company, for transfer to the prospective purchaser share certificates in respect
of all Shares to be sold by such Co-Sale Right Holder and a transfer form signed by such Co-Sale Right Holder, which indicates: 

(i)    the number of Ordinary Shares which such Co-Sale Right Holder elects to
sell; 
 (ii)    that number of Preferred Shares which is at such time convertible into the number of Ordinary Shares
that such Co-Sale Right Holder elects to sell; or 

  
 18 

 (iii)    any combination of the foregoing; 

provided, however, that if the prospective purchaser objects to the delivery of Preferred Shares in lieu of Ordinary Shares, such Co-Sale Right Holder shall convert such Preferred Shares into Ordinary Shares and deliver Ordinary Shares. The Company agrees to make any such conversion concurrent with the actual transfer of such shares to the
purchaser. 
 5.2    Procedure at Closing. The share certificate or certificates that such Co-Sale Right Holder delivers to the Selling Shareholder pursuant to paragraph 5.1(b) shall be transferred to the prospective purchaser in consummation of the sale of the Transfer Shares pursuant to the terms and
conditions specified in the Transfer Notice, and the Selling Shareholder shall concurrently therewith remit to such Co-Sale Right Holder that portion of the sale proceeds to which such Co-Sale Right Holder is entitled by reason of its participation in such sale. To the extent that any prospective purchaser or purchasers prohibit such assignment or otherwise refuse to purchase shares or other
securities from a Co-Sale Right Holder exercising its rights of co-sale hereunder, the Selling Shareholder shall not sell any Transfer Shares to such prospective
purchaser or purchasers unless and until, simultaneously with such sales, the Selling Shareholder shall purchase such shares or other securities from such Co-Sale Right Holder. In selling their Shares pursuant
to their co-sale right hereunder, the Co-Sale Right Holder shall not be required to give any representations or warranties with respect to their Shares to be sold except
to confirm that they have not transferred or encumbered such Shares. 

5.3    Non-Exercise. To the extent that there are any Transfer Shares not
purchased by the Non-Selling Shareholders in accordance with Section 4.2, and subject to the right of the Co-Sale Right Holders to exercise their rights to
participate in the sale of the relevant remaining Transfer Shares within the time periods specified in Section 5.1, the Selling Shareholder may, not later one hundred and twenty (120) days following delivery of the Transfer Notice to each Non-Selling Shareholder, effect a transfer of the remaining Transfer Shares covered by the Transfer Notice not elected to be purchased by the Non-Selling Shareholders subject
to the participation of the Co-Sale Right Holders. Any proposed transfer on terms and conditions more favorable than those described in the Transfer Notice, as well as any subsequent proposed transfer of any
Shares by the Selling Shareholder, shall be subject to the procedures described in Section 4 and this Section 5. 

5.4    Legend. 

(a)    Each certificate representing the Ordinary Shares shall be endorsed with the following legend: 

“THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER SET FORTH
IN A SHAREHOLDERS AGREEMENT, AS AMENDED FROM TIME TO TIME, A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.” 

(b)    Each Party agrees that the Company may instruct its transfer agent to impose transfer restrictions on the shares
represented by certificates bearing the legend referred to in Section 5.4(a) above to enforce the provisions of this Agreement and the Company agrees to promptly do so. The legend shall be removed upon termination of the provisions of this
Section 5. 

  
 19 

 6.    ASSIGNMENT AND AMENDMENT. 

6.1    Assignment. Notwithstanding anything herein to the contrary: 

(a)    Information Rights. The rights of the Investor under Sections 2.1 and 2.2 are transferable prior to the
Qualified IPO to any Person who holds or is acquiring Investment Securities in a permitted transfer; provided, however, that the Company is given a written notice at the time of such assignment stating the name and address of the
assignee and identifying the securities of the Company as to which the rights in question are being assigned; and provided further that any such assignee shall receive such assigned rights, subject to all the terms and conditions of this
Agreement, including the provisions of this Section 6, and agree to abide by this Agreement by executing an Adherence Agreement as provided in Section 6.1(d). 

(b)    Registration Rights. The registration rights of the Holders under Section 3 are fully assignable to any
Person who holds or is acquiring Registrable Securities in a permitted transfer; provided, however, that the Company is given a written notice at the time of such assignment stating the name and address of the assignee and identifying
the securities of the Company as to which the rights in question are being assigned; and provided further that any such assignee shall receive such assigned rights, subject to all the terms and conditions of this Agreement, including the
provisions of this Section 6, and agree to abide by this Agreement by executing an Adherence Agreement as provided in Section 6.1(d). 

(c)    Right of Participation and Co-Sale Right. The Right of Participation
and Co-Sale right of each holder of the Preferred Shares under Section 4 and Section 5 hereof are fully assignable to such holder’s Affiliates or to any Person who holds or is acquiring
Preferred Shares in a permitted transfer; provided, however, that the transferee executes and delivers an Adherence Agreement as provided in Section 6.1(d). 

(d)    Adherence Agreement. For any transfer of Shares to be deemed effective, the transferee shall assume the
obligations of the transferor under this Agreement by executing and delivering to the Company an Adherence Agreement substantially in the form attached hereto as Exhibit B (“Adherence Agreement”). Upon the execution
and delivery of an Adherence Agreement by any transferee, such transferee shall be deemed to be an Ordinary Shareholder, Investor, or Holder hereunder, as appropriate. By their execution hereof, each of the Parties hereto appoints the Company as its
attorney-in-fact for the limited purpose of executing any Adherence Agreement which may be required to be delivered pursuant to this Section 6.1(d). 

6.2    Amendment. Subject to Section 6.1, this Agreement may only be amended with the written consent of
(i) the Company; (ii) Preferred Majority; and (iii) Ordinary Majority. Any amendment effected in accordance with this Section 6.2 shall be binding upon each Party hereto and their respective successors; provided that Company
shall promptly give written notice thereof to any Party hereto that has not consented to such amendment, provided that such amendment shall not adversely affect the rights, preferences or privilages of any Investor, otherwise such amendment shall
only be binding on such Investor upon its written consent. 
 6.3    Waiver of Rights. To the extent that the any
Party seeks a waiver of rights from any other Party, (i) any holder of Preferred Shares may waive any of its rights hereunder without obtaining the consent of any other holders of Preferred Shares; (ii) any Ordinary Shareholder may waive
any of its rights hereunder without obtaining the consent of any other Ordinary Shareholders; and any Group Company may waives any of its rights hereunder without obtaining the consent of any other Group Company. Any Party may waive compliance by
any other Party with any term or provision of this Agreement that such other Party was or is obligated to comply with or perform for the benefit of such waiving Party. 

  
 20 

	7.	 PROTECTIVE PROVISIONS.  

7.1    Shareholder’s Protective Provision. So long as any Preferred Shares are outstanding, any
action (whether by amendment of the Company’s Restated M&A or otherwise, and whether in a single transaction or a series of related transactions) that effects or approves any of the transactions listed in Part I of Exhibit
A involving the Company or any of its Subsidiaries shall require the approval of Preferred Majority. 

7.2    Director’s Protective Provision. So long as any Preferred Shares are outstanding, any action (whether
by amendment of the Company’s Restated M&A or otherwise, and whether in a single transaction or a series of related transactions) that effects or approves any of the transactions listed in Part II of Exhibit A involving the
Company or any of its Subsidiaries shall require the prior approval of all the Investor Directors. 
 7.3    For
purposes of this Section 7 and the Exhibit A, all references to the “Company” shall refer to each Group Company and their respective Subsidiaries. 
  

	8.	 BOARD REPRESENTATION; COMMITTEE AND SENIOR MANAGEMENT. 

8.1    Designation Right. The Company’s Restated M&A shall provide that the Company’s Board shall
consist of up to nine (9) members, which number of members shall not be changed except pursuant to an amendment to the Restated M&A. Eastern Bell shall have the right to designate one (1) Director (the “Eastern
Bell Director”), provided that Eastern Bell holds not less than 8% of the Ordinary Shares (assuming conversion of all convertible securities) then outstanding. Trustbridge shall have the right to designate one
(1) Director (the “Trustbridge Director”), provided that Trustbridge holds not less than 8% of the Ordinary Shares (assuming conversion of all convertible securities) then outstanding. Crescent shall have the
right to designate one (1) Director (the “Crescent Director”), provided that Crescent holds not less than 8% of the Ordinary Shares (assuming conversion of all convertible securities) then outstanding. CDH shall have the
right to designate one (1) Director (the “CDH Director”, together with the Eastern Bell Director, the Trustbridge Director and the Crescent Director, collectively, the “Investor
Directors”), provided that CDH holds not less than 3.5% of the Ordinary Shares (assuming conversion of all convertible securities) then outstanding. The Ordinary Majority shall have the right to appoint and remove five
(5) Directors (collectively, the “Ordnary Share Directors”), one (1) of which shall be determined by the Ordinary Majority at any time, provided that if at any time the board seat of such last Ordinary Share
Director is vacant, the voting power of the last Ordinary Share Director shall be casted on XIAO Shanglue (肖尚略),
as long as XIAO Shanglue (肖尚略) then serves as a Director, subject to any applicable laws in the Cayman
Islands. Any vacancy on the Board occurring because of the death, resignation or removal of a Director shall be filled by the vote or written consent of the same shareholder or shareholders who nominated and elected such Director. The
Series B+ Investor shall have the right to collectively appoint one (1) observer to the board of directors of the Company to attend the meetings of the Board or any committes under the Board in a
non-voting observer capacity (such individual, the “Series B+ Observer”), provided that, if any Series B+ Investor fails to close the investment contemplated under the Share Purchase
Agreement, the right of the Series B+ Investors to appoint the Series B+ Observer shall be forfeited. 

  
 21 

 8.2    Compensation Committee. If and when the Board deems
necessary, the Company shall establish and maintain a compensation committee (the “Compensation Committee”), and the Investor Directors shall be members of such Compensation Committee and shall be required to establish a quorum for
any meeting or action to be taken by such committee. Subject to Section 7, the Compensation Committee shall propose the terms of the Company’s share incentive plans to the Board for approval and adoption pursuant to the Restated M&A
and shall have the power and authority to (a) administer the Company’s share incentive plans (including the ESOP), and (b) approve all management compensation levels and arrangements, and shall have such other powers and authorities
as the Board shall delegate to it. 
 8.3    Board Quorum; Meetings, etc. The quorum (which shall exist at the
time of the voting as well as the attendance of the Board meeting) of the meetings of the Board shall be five (5) directors, including the presence, in Person or by telephone, electronic or other means of communication, of all the Investor
Directors, provided, however, that if such quorum cannot be obtained for a Board meeting after the notice of such Board meeting has been sent by the Company not less than fourteen (14) days’ prior to the scheduled meeting,
the meeting shall be adjourned to the same day of the next week at which the attendance of any directors shall constitute a quorum provided further that matters discussed in such adjourned meeting shall be limited to those stated in the
written notices and agendas of the Board meetings. Minutes of Board meetings shall be sent to Investors within thirty (30) days after the relevant meeting. The Company shall hold Board meetings at least once a quarter. 

8.4    Assignment. The rights of the Investors set forth in this Section 8 are fully assignable to any Person
who holds or is acquiring the Preferred Shares in a permitted transfer; provided, however, that the Company is given a written notice at the time of such assignment stating the name and address of the assignee and identifying the
securities of the Company as to which the rights in question are being assigned; provided further, that the transferee executes and delivers an Adherence Agreement. 

8.5    Management of the Group Companies. The board of each Group Company other than the Company, including
but not limited to the PRC Compnies, shall at all times consist of the same members of the Board of the Company, and each of the Parties hereto shall take all such necessary or advisable actions to ensure the appointment of such Persons designated
by the Investors to the board of each Group Company. Each Group Company shall only take actions that have been previously approved by the board of directors of each Group Company as established pursuant to this Section 8.5. 

8.6    Insurance and Indemnification. The Company shall procure customary directors and officers insurance for the
directors. Notwithstanding anything to the contrary in this Agreement or in the Restated M&A, each Group Company shall, jointly and severally, indemnify and hold harmless each Investor Director and his/her alternate, to the fullest extent
permissible by law, from and against all liabilities, damages, actions, suits, proceedings, claims, costs, charges and expenses suffered or incurred by or brought or made against such Investor Director or his/her alternate as a result of any act,
matter or thing done or omitted to be done by him/her in good faith in the course of acting as a Director or alternate Director, as applicable, of the Company or any Group Company, by delivering to such Investor Director or his/her alternate, at the
time of his/her appointment as a Director or an alternate Director, an indemnification agreement duly executed by the Company substantially in the form satisfactory to the Investor. In addition, the Company shall indemnify each Investor to the
maximum extent permitted by applicable laws for any claims brought against such Investor by any third party (including any other Shareholder of the Company) as a result of such Investor’s investment in the Company. 

  
 22 

 8.7    Director Expenses. The Company shall reimburse Investor
Directors and the Series B+ Observer for all reasonable out-of-pocket expenses incurred in connection with Board duties and meetings. 

 

	9.	 SALE OF THE COMPANY. 

9.1    Drag-Along. 

(a)    If the Ordinary Majority and the Preferred Majority (collectively, the “Drag Holders”) approve a
Trade Sale with a pre-money valuation of the Company at no less than US$4,000,000,000 (or equivalent RMB) (such sale, transfer, conveyance or assignment pursuant to this Section 9.1, a “Drag-Along
Sale”) at any time after the Closing, at the request of the Drag Holders, then each remaining Shareholder (the “Dragged Holders”) shall sell, transfer, convey or assign its Shares pursuant to,
and so as to give effect to, such offer to purchase, merger or consolidation, sale or transfer, as the case may be, unless the rejecting Dragged Holder agrees to purchase the Shares proposed to be sold, transferred, conveyed or assigned by the Drag
Holders under the proposed Drag-Along Sale. If the consideration offered is payable in securities or property other than cash (or evidence of cash indebtedness), the Board (including the affirmative votes of all the Investor Directors) shall in good
faith determine the fair market value of any such securities or property in cash, provided that any holder of Preferred Shares shall have the right to challenge any determination by the Board of fair market value made pursuant hereto, in which case
the determination of fair market value shall be made by a valuer selected jointly by the Board (including the affirmative votes of all the Investor Directors) and the challenging Parties. The valuer shall prepare a report setting forth the basis of
its calculating such fair market value, and the determination of such fair market value by the valuer shall, in the absence of manifest error, be final and conclusive. The costs of the valuer shall be borne solely by the Company. The valuer shall
act as expert and not as an arbitrator. If the acquiring party is a privately-held entity and the holders of Preferred Shares receive in whole or in part non-publicly traded securities of such acquirer, then
such non-publicly traded securities shall have liquidation preference(s), protective provision(s), voting right(s), dividend right(s), registration rights and preemptive rights that are substantially similar
to those of the Preferred Shares, as applicable, as set forth herein as of the date hereof, unless otherwise agreed by the Preferred Majority. 

(b)    Subject to the Charter Documents of the Company, the consideration to be received by a Dragged Holder shall be the
same form and amount of consideration per share of Ordinary Share to be received by the Drag Holder (or, if the Drag Holders are given an option as to the form and amount of consideration to be received, the same option shall be given to the Dragged
Holders) and the terms and conditions of such sale shall, except as otherwise provided in the immediately succeeding sentence, be the same as those upon which the Drag Holders sell their Ordinary Shares. Each Dragged Holder shall make or provide
customary representations, warranties, covenants, indemnities and agreements in connection with the Drag-Along Sale; provided, that all representations, warranties, covenants and indemnities shall be made by each Drag Holder and each Dragged
Holder severally but not jointly. 
 (c)    The restrictions on Transfers of Shares set forth in Sections 10.1, 4.2 and
5 shall not apply in connection with a sale pursuant to this Section 9.1, or anything in this Agreement to the contrary notwithstanding. 

  
 23 

 (d)    Upon the approval of a Drag-Along Sale as described in this
Section 9.1, each Shareholder (other than Drag Holders) shall grant to the chief executive officer (“CEO”) or an authorized officer, a power of attorney to transfer their Shares and to do and carry out all other necessary or
advisable acts to complete the Drag-Along Sale, including, without limitation, executing any and all documents (including instruments of transfer) on behalf of such Shareholder. The CEO or an authorized officer shall be authorized to transfer the
Shares of each such Shareholder and to do and carry out all other necessary or advisable acts to complete the Drag-Along Sale, including, without limitation, executing any and all documents (including instruments of transfers) on behalf of each such
Shareholder. 
  

	10.	 COVENANTS. 

10.1    Restrictions on Transfers. Subject to Sections 4 and 5 and the provisions of any severance agreement that
the Founders may enter into, each Founder agrees that, without the prior written consent of the Preferred Majority, he shall not, directly or indirectly, sell, transfer, pledge, encumber, hypothecate or otherwise dispose of any of his Shares in the
Company or any of other Group Companies. In the case that any Share is held by its ultimate beneficial owner through one or more level of holding companies, any transfer, repurchase, or new issuance of the shares of such holding companies or similar
transactions that have the effect of change the beneficial ownership of such Share shall be deemed as an indirect transfer of such Shares. The Parties agree that the restrictions on the transfer of the Shares held by the Founders contained in this
Agreement shall apply to such indirect transfer and shall not be circumvented by means any indirect transfer of the Shares. Notwithstanding anything to the contrary contained herein, the transfer restriction shall not apply to transfer of Shares now
or hereafter directly or indirectly held by any Founder, to the parents, children or spouse, or to trusts for the benefit of such Persons, of any holder of Shares for bona fide estate planning purposes (each transferee pursuant to the foregoing, a
“Permitted Transferee”); provided that adequate documentation therefor is provided to the Preferred Shareholders to their satisfaction and that any such Permitted Transferee agrees in writing to be bound by this Agreement and
the Restated M&A in place of the relevant transferor; provided, further, that such transferor shall remain liable for any breach by such Permitted Transferee of any provision hereunder. Each Preferred Shareholder is entitled to,
directly or indirectly, sell, transfer, pledge, encumber, hypothecate or otherwise dispose of any of its Shares in the Company or any of other Group Companies to any third party, except that none of the Preferred Shareholders may, without the prior
written consent of the Ordinary Majority, transfer any Preferred Shares or Conversion Shares to any third party which is engaged in the business similar or competitive with the principal business of the Group Companies (the
“Competitor”) or any Affiliate of any Competitor. 
 10.2    Full Time Commitment. The Actual
Controller undertakes and covenants to the Investors that, unless otherwise agreed by the Preferred Majority, during his tenure at any Group Company, he shall serve the Group Company on a full time basis and commit all of his efforts to furthering
the business and protecting the benefits of the Group Companies and shall not devote time to carry out the business operation of any other entity (except for his part-time position at the Smallyes Group Companies to the extent that the Actual
Controller will not participate in the daily business operation of the Smallyes Group Companies and the part-time position will not adversely affect the business of any Group Company). 

  
 24 

 10.3    Non-Competition.
The Actual Controller hereby undertakes and covenants to the Investors that during the Relevant Period and Restriction Period, without the prior written consent of the Preferred Majority, except for the specific arrangement with the Smallyes Group
Companies as follows, neither the Actual Controller nor any of his associates will directly or indirectly, either by himself or in conjunction with or through any other Person: 

(a)    participate, assist, be concerned with, engaged or interested in, any business or entity (other than the Smallyes
Group Companies) in any manner, directly or indirectly, which is in competition with the business carried on by any Group Company; 

(b)    except for the existing investment in the Smallyes Group Companies, invest in any form (including without
limitation, becoming the owner, shareholder, actual controller or owns any interests in other form) in any Competitor or establish any new company or other business entity; 

(c)    except for the Smallyes Group Companeis, engage in any business, which is related to the principal business of the
Group Companies or is detrimental to the benefit of the Group Companis, with any Competitor, including without limitation, becoming the agent, supplier or distributor of any Competitor; 

(d)    execute any agreement or make any commitment or enter into any other similar arrangement which may limit or be
detrimential to the exisiting business of the Group Companies; 
 (e)    during the Relevant Period and Restriction
Period, solicit in any manner any Person who is or has been during the Restriction Period a customer, agent, supplier and/or contractor of any Group Company for the purpose of offering to such Person any goods or services similar to or competing
with any of the businesses conducted by any Group Company or procuring such Person to terminate its business relationship with the Group Companies; 

(f)    at any time disclose to any Person, or use for any purpose other than for the operation fo the Group Companies, any
information concerning the business, accounts, finance, transactions or intellectual property rights of any Group Company or any trade secrets or confidential information of or relating to any of the Group Companies; or 

(g)    solicit or entice away, or endeavour to solicit or entice away, any employee, officer, potential client, customer,
supplier, licensee or licensor of any Group Company, or any Perso who has a business relationship with the Group Companies. 
 The Actual
Controller further undertakes and covenants to the Investors that (i) the Group Companies shall be his exclusive entities and platform to develop business of “social retail service platform”, operate project of “Yunji
Weidian”, and conduct relevant business activities, (ii) all the business opportunities which the Actual Controller may have from time to time and may cause potential competition with the principal business of the Group Companies shall be
transferred to the Group Companies for free, and (iii) none of the Smallyes Group Companies will engage in “social retail service”, wechat store project and any other business similar or competitive with the principal business of the
Group Companies. 
 10.4    ESOP. 

(a)    As soon as practicable after the Closing, the Board shall establish and adopt an employee share option plan (the
“ESOP”) and up to a total of 191,663,158 Ordinary Shares (proportionally adjusted to reflect any share dividends, share splits, or similar transactions) will be reserved for issuance of share options pursuant to the terms and
conditions under the ESOP. To the extent practicable under PRC Laws, the Group Companies shall cause to be filed and registered with the competent local branch of the State Administration of Foreign Exchange of the PRC with respect to the
establishment and adoption of the ESOP. 

  
 25 

 (b)    Unless the Board determines otherwise (including the affirmative
votes of all the Investor Directors), all options issued or granted under the ESOP shall be subject to a minimum four (4) year vesting schedule no faster than the following, counting from the applicable grant date with respect to the total
issued options or shares: twenty-five percent (25%) each at the first anniversary of the grant date, the second anniversary of the grant date, the third anniversary of the grant date and the fourth anniversary of the grant date. 

(c)    The power and authority to administer the ESOP shall be vested to the Board or the Compensation Committee (upon its
establishment) and any decision of the Board or the Compensation Committee with respect to the administration of the ESOP shall be made by a majority of the members of the Board or the Compensation Committee, including the affirmative votes of all
the Investor Directors. 
 (d)    Except as otherwise approved by a majority of the Board (including the affirmative
votes of all the Investor Directors), the Company shall cause all future officers, directors, and employees of, and consultants to, the Company and its Subsidiaries who purchase, or receive options to purchase, shares of the Company’s Ordinary
Shares, to execute and deliver agreements in forms approved by the Board (including the affirmative votes of all the Investor Directors) providing for a right of repurchase in favor of the Company on vested and unvested shares without cost upon
termination of the employment with cause or unilateral termination of the employment by the optionees, a prohibition on the transfer of all shares prior to a Qualified IPO (unless otherwise permitted under such employee share option plan) and a
lockup or market standoff commitment after the Qualified IPO in respect of vested shares subject to the requirements that the underwriters or sponsors may have at such time. 

10.5    Lock up. Subject to the terms and conditions hereof, following the Qualified IPO of the Company, the
Founders and the Founder Holdcos, as the principals and management holders of Ordinary Shares shall be subject to any customary lock-up period to the extent requested by the lead underwriter of securities of
the Company in connection with the registration relating to such initial public offering. 
 10.6    Controlled
Foreign Corporation. The Company will provide written notice to the Investors as soon as practicable if at any time the Company becomes aware that it or any Group Company has become a “controlled foreign corporation”
(“CFC”) within the meaning of Section 957 of the United States Internal Revenue Code of 1986 (the “Code”). Upon written request of any Investor who is a United States shareholder within the meaning of
Section 951(b) of the Code, the Company will (i) use best efforts to provide in writing such information as is in its possession and reasonably available concerning its shareholders to assist the Investor in determining whether the Company
is a CFC and (ii) provide the Investor with reasonable access to such other Company information as is in the Company’s possession and reasonably available as may be required by the Investor (A) to determine the Company’s status
as a CFC, (B) to determine whether the Investor is required to report its pro rata portion of the Company’s “Subpart F income” (as defined in Section 952 of the Code) on its United States federal income tax return, or
(C) to allow the Investor to otherwise comply with applicable United States federal income tax laws. 

  
 26 

 10.7    Passive Foreign Investment Company. The Company shall use
its best efforts to avoid being a “passive foreign investment company” within the meaning of Section 1297 of the Code (“PFIC”) for the current and any future taxable year. The Company shall make due inquiry with its
tax advisors on at least an annual basis regarding its status as a PFIC, and if the Company is informed by its tax advisors that it has become a PFIC, or that there is a likelihood of the Company being classified as a PFIC for any taxable year, the
Company shall promptly notify the Investors of such status or risk, as the case may be, in each case no later than forty-five (45) days following the end of the Company’s taxable year. In connection with a “Qualified Electing
Fund” election (a “QEF Election”) made by any Investor pursuant to Section 1295 of the Code or a “Protective Statement” filed by any Investor pursuant to Treasury Regulation
Section 1.1295-3, as amended (or any successor thereto), the Company shall provide the Investor with annual financial information in the form to the satisfaction of the Investor as soon as reasonably
practicable following the end of each taxable year of the Investor (but in no event later than forty-five (45) days following the end of each such taxable year), and shall, upon the request in writing by any Investor, provide the Investor with
access to such other information, as is in the Company’s possession and reasonably available, as may be required for purposes of filing U.S. federal income tax returns in connection with such QEF Election or Protective Statement. In the event
that it is determined by the Company’s or any Investor’s tax advisors that the control documents in place between one or more of the Company’s wholly owned Subsidiaries and/or the Company, on the one hand, and any of the Group
Companies organized in the PRC that is not a wholly foreign owned enterprise, on the other hand, does not allow the Company to look through the Group Companies to their assets and income for purposes of the PFIC rules and regulations under the Code,
the Company shall use its best efforts to take such actions as are reasonably necessary or advisable, including the amendment of such control documents, to qualify for such look-through treatment of the Group Companies under the PFIC rules and
regulations under the Code. 
 10.8    Anti-Corruption. Each of the Group Companies covenants that
it shall not, and shall not permit any of its Subsidiaries or Affiliates or any of its or their respective directors, administrators, officers, managers, board of directors (supervisory and management) members, employees, independent contractors,
representatives or agents to, promise, authorize or make any payment to, or otherwise contribute any item of value to, directly or indirectly, any non-U.S. official, in each case, in violation of the FCPA, the
U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company further covenants that it shall, and shall cause each of its Subsidiaries and Affiliates to, cease all of its or their respective activities, as well as
remediate any actions taken by the Company, its Subsidiaries or Affiliates, or any of its or their respective directors, administrators, officers, managers, board of directors (supervisory and management) members, employees, independent contractors,
representatives or agents in violation of the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company further covenants that it shall, and shall cause each of its Subsidiaries and Affiliates to, maintain
systems of internal controls (including, but not limited to, accounting systems, purchasing systems and billing systems) to ensure compliance with the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption law. 

10.9    Internal Control System. The Group Companies shall maintain their books and records in accordance with
sound business practices and implement and maintain an adequate system of procedures and controls with respect to finance, management, and accounting that meets national standards of good practice and is reasonably satisfactory to the Preferred
Majority to provide reasonable assurance that (i) transactions by it are executed in accordance with management’s general or specific authorization, (ii) transactions by it are recorded as necessary to permit preparation of financial
statements in conformity with, at the election of the Preferred Majority, the IAS, the U.S. GAAP or other international accounting standard and to maintain asset accountability, (iii) access to assets of it is permitted only in accordance with
management’s general or specific authorization, (iv) if applicable, the recorded inventory of assets is compared with the existing tangible assets at reasonable intervals and appropriate action is taken with respect to any material
differences, (v) segregating duties for cash deposits, cash reconciliation, cash payment, proper approval is established, and (vi) no personal assets or bank accounts of the employees, directors, officers are mingled with the corporate
assets or corporate bank account, and no Group Company uses any personal bank accounts of any employees, directors, officers thereof during the operation of the business. 

  
 27 

 10.10    Investors’ Right to Appoint Nominee Shareholders in
Domestic Co. and New VIE Company. As soon as practical and upon request of any Investor (for so long as such Investor remains a Shareholder of the Company), the Group Companies and the Founders shall cause the equity structure of the Domestic
Co. and/or the New VIE Company (as defined in the Share Purchase Agreement) to be restructured so that immediately after such restructuring, the nominee shareholder designated by such Investor shall hold such equity interest in the Domestic Co.
and/or the New VIE Company at a nominal price that mirrors such Investor’s shareholding percentage in the Company (calculated on a fully diluted and as-converted basis); provided that (i) the
shareholding percentage of such nominee shareholder in the the Domestic Co. and/or the New VIE Company shall be decreased along with any decrease of such Investor’s shareholding percentage in the Company (calculated on a fully diluted and as-converted basis), so that the shareholding percentage of such nominee shareholder in the the Domestic Co. and/or the New VIE Company shall in any event no more than such Investor’s shareholding percentage in
the Company (calculated on a fully diluted and as-converted basis) and (ii) all the fees and taxes incurred during such restructuring shall be assumed by such Investor and its nominee shareholder. 

 

	11.	 CONFIDENTIALITY AND NON-DISCLOSURE. 

11.1    Disclosure of Terms. Each Party hereto acknowledges that the terms and conditions (collectively, the
“Terms”) of this Agreement, the other Transaction Documents, and all exhibits, restatements and amendments hereto and thereto, including their existence, shall be considered confidential information and shall not be disclosed by it
to any third party except in accordance with the provisions set forth below. Each Investor agrees with the Company that such Investor will keep confidential and will not disclose or divulge, any information which such Investor obtains from the
Company, pursuant to financial statements, reports, presentations, correspondence, and any other materials provided by the Company to, or communications between the Company and such Investor, or pursuant to information rights granted under this
Agreement or any other related documents, unless the information is known, or until the information becomes known, to the public through no fault of such Investor, or unless the Company gives its written consent to such Investor’s release of
the information. 
 11.2    Press Releases. Within sixty (60) days of the Closing, the Company may issue a
press release related to the Closing, disclosing that any Investor has invested in the Company provided that (a) the release does not disclose any of the Terms, (b) the press release does not disclose the amount or other specific terms of
the investment, and (c) the final form of the press release is approved in advance in writing by the Investor(s) mentioned therein. The Investor’s names and the fact that the Investors are shareholders in the Company can be included in a
reusable press release boilerplate statement, so long as the relevant Investor has given the Company its initial approval of such boilerplate statement and the boilerplate statement is reproduced in exactly the form in which it was approved. No
other announcement regarding any Investor in a press release, conference, advertisement, announcement, professional or trade publication, mass marketing materials or otherwise to the general public may be made without the relevant Investor’s
prior written consent, which consent may be withheld at such Investor’s sole discretion. 

  
 28 

 11.3    Permitted Disclosures. Notwithstanding anything in the
foregoing to the contrary, 
 (a)    the Company may disclose any of the Terms to its current or bona fide prospective
investors, directors, officers, employees, shareholders, investment bankers, lenders, accountants, auditors, insurers, business or financial advisors, and attorneys, in each case only where such Persons or entities are under appropriate
nondisclosure obligations imposed by professional ethics, law or otherwise; 
 (b)    any Investor (and its fund
manager) may disclose the Investor’s investment in the Company to third parties or to the public at its sole discretion and in relation thereto may use the Company’s logo and trademark and may include links to the Company’s website
(without requiring the Company’s further consent). If it does so, the other Parties shall have the right to disclose to third parties any such information disclosed in a press release or other public announcement by the Investor; 

(c)    any Investor shall have the right to disclose: 

(i)    any information to the Investor’s Affiliate or fund manager, the Investor’s and/or its fund
manager’s and/or its Affiliate’s legal counsel, fund manager, auditor, insurer, accountant, consultant or to an officer, director, general partner, limited partner, fund manager, shareholder, investment counsel or advisor, or employee of
the Investor, fund manager, or Affiliate or any of their respective investors or Affiliates, provided, however, that any counsel, auditor, insurer, accountant, consultant, officer, director, general partner, limited partner, fund
manager, shareholder, investment counsel or advisor, or employee shall be advised of the confidential nature of the information or are under appropriate non-disclosure obligation imposed by professional
ethics, law or otherwise; 
 (ii)    any information for fund and inter-fund reporting purposes; 

(iii)    any information as required by law, government authorities, exchanges and/or regulatory bodies, including by the
Securities and Futures Commission of the Hong Kong, the China Securities and Regulatory Commission of the PRC or the Securities and Exchange Commission of the United States (or equivalent for other venues); 

(iv)    any information to bona fide prospective purchasers/investors of any share, security or other interests in the
Company, and/or 
 (v)    any information contained in press releases or public announcements of the Company pursuant
to Section 11.2 above. 
 (d)    the confidentiality obligations set out in this Section 11 do not apply to:

 (i)    information which was in the public domain or otherwise known to the relevant Party before it was furnished
to it by any other Party hereto or, after it was furnished to that Party, entered the public domain otherwise than as a result of (i) a breach by that Party of this Section 11 or (ii) a breach of a confidentiality obligation by the
discloser, where the breach was known to that Party; 
 (ii)    information the disclosure of which is necessary in
order to comply with any applicable law, the order of any court, the requirements of a stock exchange or to obtain tax or other clearances or consents from any relevant authority; or 

  
 29 

 (iii)    the disclosure of information by any director of the Company
to its appointer or any of its affiliate or otherwise in accordance with the foregoing provisions of this Section 11.3. 

11.4    Legally Compelled Disclosure. In the event that any Party is requested or becomes legally compelled
(including without limitation pursuant to securities laws and regulations) to disclose the existence of this Agreement or any Terms in contravention of the provisions of this Section 11, such Party (the “Disclosing Party”)
shall if and to the extent that it can lawfully do so provide the other Parties (the “Non-Disclosing Parties”) with prompt written notice of that fact so that the appropriate Party may seek
(with the cooperation and reasonable efforts of the other Parties) a protective order, confidential treatment or other appropriate remedy. In such event, the Disclosing Party shall furnish only that portion of the information that is legally
required and shall exercise reasonable efforts to obtain reliable assurance that confidential treatment will be accorded such information to the extent reasonably requested by any Non-Disclosing Party. 

11.5    Use of CDH’s Name or Logo. Without the prior written consent of CDH, and whether or not it or any
Affiliate thereof is then a Shareholder of the Company, no Party hereto other than CDH itself shall or shall permit any Affiliate thereof to use, publish or reproduce the name or logo of CDH, or any similar name, trademark or logo in any manner,
context or format (including references on or links to websites, in press releases, or in other public announcements). 
  

	12.	 MISCELLANEOUS. 

12.1    Effectiveness. This Agreement shall come into effect as of execution by all the Parties hereto,
provided that, in respect of each New Investor, it shall become a Party to this Agreement and enjoy the rights and undertake the obligations hereunder only upon its being registered as a Shareholder of the Company pursuant to the Share Purchase
Agreement. 
 12.2    Governing Law. This Agreement shall be governed in all respects by the laws of the Hong
Kong without regard to conflicts of law principles. 
 12.3    Successors and Assigns. Except as otherwise
expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, permitted assigns, heirs, executors and administrators of the Parties hereto whose rights or obligations hereunder are affected by
such provisions. Except as expressly stated otherwise, the rights of any Investor set forth in this Agreement are fully assignable to any Person (other than any Competitor) who holds or is acquiring Shares from such Investor. Each transferee,
successors, or assignee of an Investor shall become a party of this Agreement by executing and delivering to the Company an Adherence Agreement in the form attached hereto as Exhibit B. 

12.4    Third Parties. Nothing in this Agreement, express or implied, is intended to confer upon any Person, other
than the Parties hereto and their permitted successors and assigns, any rights or remedies under or by reason of this Agreement. 

12.5    Entire Agreement. This Agreement, the Share Purchase Agreement and any other Transaction Document, together
with all the schedules and exhibits hereto and thereto, which are hereby expressly incorporated herein by this reference, constitute the entire understanding and agreement between the Parties with regard to the subjects hereof and thereof and
supersede all prior agreements and undertakings, both written and oral, among the Parties with respect to the subject matter hereof and thereof (including the Prior Shareholders Agreement); provided, however, that nothing in this
Agreement or related agreements shall be deemed to terminate or supersede the provisions of any confidentiality and nondisclosure agreements executed by the Parties hereto prior to the date of this Agreement, all of which agreements shall continue
in full force and effect until terminated in accordance with their respective terms. 

  
 30 

 12.6    Notices. Except as may be otherwise provided herein, all
notices, requests, waivers and other communications made pursuant to this Agreement shall be in writing and shall be conclusively deemed to have been duly given (a) when hand delivered to the other Party; (b) when sent by facsimile at the
number set forth below, upon a successful transmission report being generated by the sender’s machine; (c) when sent by email, upon the date of successful transmission, provided that the sending Party has received a system message
indicating successful transmission or has not received a system message within 24 hours indicating failure of delivery or return of email; or (d) three (3) Business Days after deposit with an internationally-recognized overnight delivery
service, postage prepaid, addressed to the Parties as set forth in Exhibit C with next-business-day delivery guaranteed, provided that the sending Party receives a confirmation of delivery from the delivery
service provider. 
 Each Person making a communication hereunder by facsimile shall promptly confirm by telephone to the Person to whom
such communication was addressed each communication made by it by facsimile pursuant hereto but the absence of such confirmation shall not affect the validity of any such communication. A Party may change or supplement the addresses given in
Exhibit C, or designate additional addresses, for purposes of this Section 12.6, by giving the other Parties written notice of the new address in the manner set forth above. 

12.7    Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any Party upon
any breach or default of any other Party hereto under this Agreement, shall impair any such right, power or remedy of the aggrieved Party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any
similar breach or default thereafter occurring; nor shall any waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any Party of any breach or
default under this Agreement or any waiver on the part of any Party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under
this Agreement, or by law or otherwise afforded to the Parties shall be cumulative and not alternative. 

12.8    Interpretation; Titles and Subtitles. This Agreement shall be construed according to its fair language. The
rule of construction to the effect that ambiguities are to be resolved against the drafting Party shall not be employed in interpreting this Agreement. The titles of the sections and subsections of this Agreement are for convenience of reference
only and are not to be considered in construing this Agreement. 
 12.9    Counterparts. This Agreement may be
executed in one or more counterparts and may be delivered by electronic PDF or facsimile transmission, all of which shall be considered one and the same agreement and each of which shall be deemed an original. 

12.10    Severability. Should any provision of this Agreement be determined to be illegal or unenforceable, such
determination shall not affect the remaining provisions of this Agreement. 

  
 31 

 12.11    Adjustment for Share Splits, etc. Whenever in this
Agreement there is a reference to a specific number or percentage of the Preferred Shares, then, upon the occurrence of any subdivision, combination or share dividend of the Preferred Shares, the specific number of shares so referenced in this
Agreement shall automatically be proportionally adjusted to reflect the effect on the outstanding shares of such class or series of shares by such subdivision, combination or share dividend. 

12.12    Pronouns and etc. For all purposes of this Agreement, except as otherwise expressly
provided, (a) the defined terms shall have the meanings assigned to them in its definition and include the plural as well as the singular, and pronouns of either gender or neuter shall include, as appropriate, the other pronoun forms;
(b) all references in this Agreement to designated “Sections” and other subdivisions are to the designated Sections and other subdivisions of the body of this Agreement unless explicitly stated otherwise, and all references in this
Agreement to designated exhibits, schedules and annexes are to the exhibits, schedules and annexes attached to this Agreement unless explicitly stated otherwise, (c) the words “herein”, “hereof”, and “hereunder”
and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision, (d) any reference in this Agreement to any “Party” or any other Person shall be construed so as to include
its successors in title, permitted assigns and permitted transferees, and (e) any reference in this Agreement to any agreement or instrument is a reference to that agreement or instrument as amended or novated. 

12.13    Dispute Resolution. 

(a)    Negotiation Between Parties. The Parties agree to negotiate in good faith to resolve any dispute between them
regarding this Agreement. If the negotiations do not resolve the dispute to the reasonable satisfaction of the relevant Parties within thirty (30) days after the occurrence of the dispute, either Party to the dispute may begin formal
arbitration proceedings to be conducted in accordance with subsection (b) below. 
 (b)    Arbitration. In
the event the Parties are unable to settle a dispute between them regarding this Agreement in accordance with subsection (a) above, such dispute shall be referred to and finally settled by arbitration at the Hong Kong International Arbitration
Centre in accordance with the Hong Kong International Arbitration Centre Administered Arbitration Rules (the “HKIAC Rules”) then in force, which rules are deemed to be incorporated by reference into this subsection (b), subject to
the following: (i) the arbitration tribunal shall consist of three (3) arbitrators to be appointed according to the HKIAC Rules; and (ii) the language of the arbitration shall be Chinese. The prevailing party shall be entitled to
reasonable attorney’s fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. The award of the arbitral tribunal shall be final and binding upon the Parties thereto, and the prevailing Party
may apply to a court of competent jurisdiction for enforcement of such award. 
 12.14    Shareholders Agreement to
Prevail. If and to the extent that there are inconsistencies between the provisions of this Agreement and those of the Restated M&A, the terms of this Agreement shall prevail except, as regards the Company the Restated M&A of the Company
shall prevail. The Parties (other than the Company with respect to the Restated M&A of the Company) agree to take all actions necessary or advisable, as promptly as practicable after the discovery of such inconsistency, to amend the Restated
M&A so as to eliminate such inconsistency. 

  
 32 

 12.15    Termination. This Agreement and all rights and covenants
contained herein, except for obligations set forth in Sections 1, 3, 6, 10, 11, and 12, shall terminate on the closing of a Qualified IPO or a Deemed Liquidation Event, whichever shall first occur. If for the purpose of a Qualified IPO and as
approved by the Preferred Majority, the Group Companies are required or advised by their counsel to conduct a reorganization, the Preferred Majority may elect to waive any or all of its preferred or special rights hereunder, effective as of the
completion of such reorganization; provided that, in the event that the Qualified IPO does not occur within twelve (12) months after the completion of such reorganization, each of the Group Companies, the Founders and the Founder Holdcos
shall take all such actions as necessary or desirable to restore all the rights and privileges of the Investors contained herein, including without limitation (i) causing the Company to amend the Restated M&A, (ii) causing the Company
to issue to the Investors applicable class and number of shares of the Company, and (iii) entering into agreements containing substantially the same terms and conditions hereof. 

12.16    Waiver from Existing Investors. Each of the Investors (other than the New Investors) hereby irrevocably
and unconditionally waives and releases each of the Warrantors (as defined in the Share Purchase Agreement) from any claims such Investor may have for the failure of any Warrantor to comply with any obligations under the previous share purchase
agreements, capital increase agreements and investment agreements entered into by and among the Warrantors, the Investor(s) and their respective Affiliates (to the extend applicable), and certain parties thereto before the date of the Share Purchase
Agreement. 
 (The remainder of this page has been left blank intentionally.) 

  
 33 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE COMPANY:
	
	Yunji Inc.
		
	By:	 	 /s/ XIAO Shanglue

	Name:	 	XIAO Shanglue (肖尚略)
	Title:	 	Director
	
	THE HK CO.:
	
	Yunji Holding Limited (雲集控股有限公司)
		
	By:	 	 /s/ XIAO Shanglue

	Name:	 	XIAO Shanglue (肖尚略)
	Title:	 	Director
	
	DOMESTIC CO.:
	
	 Yunji Sharing Technology Co., Ltd.

(云集共享科技有限公司)

	(/s/ Seal of Yunji Sharing Technology Co., Ltd.)
		
	By:	 	 /s/ XIAO Shanglue

	Name:	 	XIAO Shanglue (肖尚略)
	Title:	 	Legal Representative
	
	THE OPERATING CO.:
	
	 Zhejiang Jishang Youxuan E-Commerce Co., Ltd.

(浙江集商优选电子商务有限公司
)

	 (/s/ Seal of Zhejiang Jishang Youxuan E-Commerce

Co., Ltd.)

		
	By:	 	 /s/ XIAO Shangce

	Name:	 	XIAO Shangce (肖尚策)
	Title:	 	Legal Representative

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE WFOE:
	
	 Hangzhou Yunchuang Sharing Network Technology Co., Ltd.

(杭州云创共享网络科技有限公司
)

	(/s/ Seal of Hangzhou Yunchuang Sharing Network Technology Co., Ltd.)
		
	By:	 	 /s/ XIAO Shanglue

	Name:	 	XIAO Shanglue (肖尚略)
	Title:	 	Legal Representative

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE FOUNDER HOLDCOS:
	
	Lanlan Ltd.
		
	By:	 	 /s/ XIAO Shanglue

	Name:	 	XIAO Shanglue (肖尚略)
	Title:	 	Director
	
	THE FOUNDERS:
		
		 	 /s/ XIAO Shanglue

	Name:	 	XIAO Shanglue (肖尚略)

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE FOUNDER HOLDCOS:
	
	Kingwangpeng Holdings Limited
		
	By:	 	 /s/ WANG Peng

	Name:	 	WANG Peng (王鹏)
	Title:	 	Director
	
	THE FOUNDERS:
		
		 	 /s/ WANG Peng

	Name:	 	WANG Peng (王鹏)

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	Eastern Bell XIX Investment Limited
		
	 By:
	 	 /s/ SUN Yanhua

	 Name:
	 	 SUN Yanhua

	 Title:
	 	 Director

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	FASTURN OVERSEAS LIMITED
		
	 By:
	 	 /s/ LIN NING DAVID

	 Name:
	 	 LIN NING DAVID

	 Title:
	 	 Authorized Representative

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	CPYD Singapore Pte. Ltd.
		
	By:	 	 /s/ Lawrence Lim

	 Name:
	 	 Lawrence Lim

	 Title:
	 	 Director

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	Eastern Bell XII Investment Limited
		
	By:	 	 /s/ YIN Junping

	Name:	 	YIN Junping
	Title:	 	Director

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	TRUSTBRIDGE PARTNERS IV, L.P.
		
	By:	 	 /s/ LIN NING DAVID

	Name:	 	LIN NING DAVID
	Title:	 	Authorized Representative

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	China Renaissance Corporation
		
	By:	 	 /s/ BAO FAN

	Name:	 	BAO FAN
	Title:	 	Director

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	Acceleration S Limited
		
	By:	 	 /s/ William Hsu

	Name:	 	William Hsu
	Title:	 	Director

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	China TH Capital Limited
		
	By:	 	 /s/ SONG Liangjing

	Name:	 	SONG Liangjing
	Title:	 	Director

  
 [Signature Page to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	Fountain Sight Limited
		
	By:	 	 /s/ Werkun Krzysztof

	Name:	 	Werkun Krzysztof
	Title:	 	Director

 [Signature Page to the Amended and Restated Shareholders Agreement – Yunji Inc.] 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first
above written. 
  

			
	THE INVESTORS:
	
	Shanghai Fengxian Information and Technology Development Partnership (LLP)
(上海丰羡信息科技发展合伙企业(有限合伙
))
	(/s/ Seal of Shanghai Fengxian Information and Technology Development Partnership (LLP))
		
	By:	 	 /s/ WANG Xinwei

	Name:	 	WANG Xinwei
	Title:	 	Authorized Representative

 [Signature Page to the Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Schedule A-1 

PRC Subsidiaries 
  

	1.	 Hangzhou Jixi Enterprise Management and Consulting Co., Ltd.
(杭州集喜企业管理咨询有限公司); 

 

	2.	 Zhejiang Youji Supply Chain Management Co., Ltd.
(浙江优集供应链管理有限公司); 

 

	3.	 Huzhou Delue Network Technology Co., Ltd.
(湖州德略网络科技有限公司); 

  

	4.	 Zhejiang Zhelue Network Technology Co., Ltd.
(浙江哲略网络科技有限公司); 

  

	5.	 Hangzhou Jichuang Network Technology Co., Ltd.
(杭州集创网络科技有限公司); 

  

	6.	 Zhejiang Jishang Youxuan E-Commerce Co., Ltd. (浙江集商优选电子商务有限公司); 

 

	7.	 Zhejiang Jishang Network Technology Co., Ltd.
(浙江集商网络科技有限公司); 

  

	8.	 Zhejiang Jiyuan Network Technology Co., Ltd.
(浙江集远网络科技有限公司); and 

 

	9.	 Anhui Delue Network Technology Co., Ltd.
(安徽德略网络科技有限公司). 

  
 [Schedule A to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Schedule A-2 

Founders 
  

			
	 Name of Founder
	  	PRC ID
	 XIAO Shanglue
(肖尚略)
	  	******
	 WANG Peng (王鹏)
	  	******

  
 [Schedule A to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Schedule A-3 

Founder Holdcos 
  

					
	 Name of the Company
	  	Place of Incorporation	  	Ownership
	 Lanlan Ltd.
	  	British Virgin Islands	  	100% owned by XIAO
Shanglue (肖尚略)
	 Kingwangpeng Holdings Limited
	  	British Virgin Islands	  	100% owned by WANG
Peng (王鹏)

  
 [Schedule A to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Schedule B-1 

Series Seed Investors 
  

							
	 Name
	  	No. of Series Seed
Preferred Shares	 	  	Purchase Price
	 FASTURN OVERSEAS LIMITED
	  	 	149,200,000	 	  	USD in equivalent to
RMB20,000,000
	 Eastern Bell XIX Investment Limited
	  	 	223,800,000	 	  	USD in equivalent to
RMB30,000,000

  
 [Schedule B to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Schedule B-2 

Series A Investors 
  

							
	 Name
	  	No. of Series A
Preferred Shares	 	  	Purchase Price
	 CPYD Singapore Pte. Ltd.
	  	 	215,800,000	 	  	US$20,000,000
	 Eastern Bell XII Investment Limited
	  	 	56,800,000	 	  	USD in equivalent to
RMB33,160,000
	 TRUSTBRIDGE PARTNERS IV, L.P.
	  	 	111,000,000	 	  	US$555
	 China Renaissance Corporation
	  	 	5,600,000	 	  	US$28

  
 [Schedule B to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Schedule B-3 

Series B Investors 
  

							
	 Name
	  	No. of Series B
Preferred Shares	 	  	Purchase Price
	 Acceleration S Limited
	  	 	110,803,324	 	  	US$100,000,000
	 China TH Capital Limited
	  	 	1,108,033	 	  	US$1,000,000

  
 [Schedule B to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Schedule B-4 

Series B+ Investors 
  

							
	 Name
	  	No. of Series B+
Preferred Shares	 	  	Purchase Price
	 Fountain Sight Limited
	  	 	5,276,349	 	  	US$5,000,000
	 Shanghai Fengxian Information and Technology Development Partnership (LLP) (上海丰羡信息科技发展合伙企业(有限合伙))

	  	 	15,829,046	 	  	US$15,000,000

  
 [Schedule B to the
Amended and Restated Shareholders Agreement – Yunji Inc.] 

 Annex A 

Definitions 

Capitalized terms used but not otherwise defined in this Agreement shall have the meanings given to them in the Share Purchase Agreement. 

“Actual Controller” shall mean XIAO Shanglue
(肖尚略). 

“Affiliate” shall mean, in respect of a Person, any other Person that, directly or indirectly, through one or more
intermediaries, Controls, is Controlled by, or is under common Control with, such Person, and without limiting the generality of the foregoing, (a) in the case of a natural Person, shall include, without limitation, such Person’s spouse,
parents, children, siblings, mother-in-law and father-in-law and brothers and sisters-in-law, (b) in the case of any Investor, shall include (i) any Person who holds Shares as a nominee for the Investor, (ii) any shareholder of the
Investor, (iii) any entity or individual which has a direct and indirect interest in the Investor (including, if applicable, any general partner or limited partner) or any fund manager thereof; (iv) any Person that directly or indirectly
Controls, is Controlled by, under common Control with, or is managed by the Investor, its shareholder, the general partner or the fund manager of the Investor or its shareholder, (v) the relatives of any individual referred to in (ii), (iii)
and (iv) above, and (vi) any trust Controlled by or held for the benefit of such individuals. For the avoidance of doubt, an Investor shall not be deemed to be an Affiliate of any Group Company. 

“Board” shall mean the board of directors of the Company. 

“Business Day” or “business day” shall mean any day that is not a Saturday, Sunday, legal holiday or a day
on which banks are required to be closed in Cayman Islands, the Hong Kong or the PRC. 
 “CDH” shall mean Acceleration S
Limited. 
 “Charter Documents” shall mean, with respect to a particular legal entity, the articles of incorporation,
certificate of incorporation, formation or registration (including, if applicable, certificates of change of name), memorandum of association, articles of association, bylaws, articles of organization, limited liability company agreement, trust
deed, trust instrument, operating agreement, joint venture agreement, business license, or similar or other constitutive, governing, or charter documents, or equivalent documents, of such entity. 

“Closing” has the meaning ascribed to it in Section 2.3 of the Share Purchase Agreement. 

“Control”, with respect to any third party, shall have the meaning ascribed to it in Rule 405 under the Securities Act, and
shall be deemed to exist for any party (a) when such party holds at least fifty percent (50%) of the outstanding voting securities of such third party and no other party owns a greater number of outstanding voting securities of such third party
or (b) over other members of such party’s immediate family. Immediate family members include, without limitation, a Person’s spouse, parents, children, siblings,
mother-in-law and father-in-law and brothers and sisters-in-law. The terms “Controlling” and “Controlled” have meanings correlative to the foregoing. 

  
 [Annex A to the Amended
and Restated Shareholders Agreement – Yunji Inc.] 

 “Conversion Shares” shall mean Ordinary Shares issuable or issued upon
conversion of the Preferred Shares of the Company. 
 “Crescent” shall mean CPYD Singapore Pte. Ltd. 

“Deemed Liquidation Event” has the meaning set forth in the Restated M&A. 

“Director” shall mean a member of the board of directors of the Company. 

“Eastern Bell” shall mean, collectively, Eastern Bell XIX Investment Limited and Eastern Bell XII Investment Limited. 

“Exchange Act” shall mean the U.S. Securities and Exchange Act of 1934, as amended. 

“FCPA” shall mean the Foreign Corrupt Practices Act of the United States (15 U.S.C. §§ 78dd-1, et seq.), as amended. 
 “Group Companies” shall mean Company, the HK Co., the
WFOE, the Domestic Co., the PRC Subsidiaries, the HK Subsidiary, and each Person (except individuals) Controlled by the Company and their respective Subsidiaries from time to time (each a “Group Company”), unless the context
specifically indicates otherwise. 
 “HK Subsidiary” shall mean Yunji HongKong Limited. 

“Hong Kong” shall mean the Hong Kong Special Administrative Region of the People’s Republic of China. 

“Huaxing” shall mean, collectively, China Renaissance Corporation, Huaxing RMB and Huaxing US. 

“Huaxing RMB” shall mean Shanghai Fengxian Information and Technology Development Partnership (LLP) (上海丰羡信息科技发展合伙企业(有限合伙)), a limited partnership established in the PRC. 

“Huaxing US” shall mean Fountain Sight Limited, a limited liability company incorporated in the British Virgin Islands. 

“IAS” shall mean the applicable International Accounting Standards published by the International Accounting Standards Board
from time to time. 
 “Intellectual Property” shall mean any and all (a) patents, patent rights, patent applications,
and all reissues, re-examinations, continuations, continuations-in-part, divisions, and patent term extensions thereof,
(b) inventions (whether patentable or not), improvements, concepts, innovations and industrial models, (c) registered and unregistered copyrights, copyright registrations and applications, author’s rights and works of authorship
(including artwork of any kind and software of all types in whatever medium, inclusive of computer programs, source code, object code and executable code, and related documentation), (d) URLs, domain names, web sites, web pages and any part thereof,
(e) technical information, know-how, trade secrets, drawings, designs, design protocols, specifications for parts and devices, quality assurance and control procedures, design tools, manuals, research
data concerning historic and current research and development efforts, including the results of successful and unsuccessful designs, databases and proprietary data, (f) proprietary processes, technology, engineering, formulae, algorithms and
operational procedures, (g) trade names, trade dress, trademarks, service marks, and registrations and applications therefor, and (h) the goodwill of the business symbolized or represented by the foregoing, customer lists and other
confidential and proprietary information and common-law rights. 

  
 [Annex A to the Amended
and Restated Shareholders Agreement – Yunji Inc.] 

 “Investment Securities” shall mean the Preferred Shares and/or the
Conversion Shares. 
 “New Investors” shall mean, collectively, TH Capital, Huaxing US and Huaxing RMB. 

“Ordinary Majority” shall mean the holders representing more than fifty percent (50%) of the Ordinary Shares then
outstanding, voting as a single class on an as-converted basis. 
 “Ordinary Shareholders” shall mean the holders of the
Ordinary Shares of the Company. 
 “Ordinary Shares” shall mean the ordinary shares of the Company, par value US$0.000005
per share. 
 “Person” shall mean any individual, sole proprietorship, partnership, limited partnership, limited liability
company, firm, joint venture, estate, trust, unincorporated organization, association, corporation, institution, public benefit corporation, entity or governmental or regulatory authority or other enterprise or entity of any kind or nature. 

“PRC” shall mean the People’s Republic of China, excluding the Hong Kong, the Macau Special Administrative Region and
the Islands of Taiwan. 
 “PRC Subsidiaries” shall mean the entities set forth on Schedule A-1, and “PRC Subsidiary” shall mean any one of such entities. 
 “Preferred
Majority” shall mean collectively, the Series Seed Majority, the Series A Majority and the Series B Majority. 
 “Preferred
Shares” shall mean the Company’s Series Seed Preferred Shares, Series A Preferred Shares, Series B Preferred, Series B+ Preferred Shares Shares and/or other preferred shares of the company that may be issued from time to time. 

“Preferred Shareholders” shall mean the holders of the Preferred Shares of the Company. 

“Qualified IPO” shall mean a public offering of Ordinary Shares of the Company (or securities representing such Ordinary
Shares) registered under the Securities Act and with an implied pre-money valuation of US$4,000,000,000 (or equivalent RMB) or more, or in a similar public offering of Ordinary Shares in a jurisdiction and on
an internationally recognized securities exchange or inter-dealer quotation system outside of the United States, including the Stock Exchange of Hong Kong Limited, the Shanghai Stock Exchange and the Shenzhen Stock Exchange, provided such public
offering is equivalent to the aforementioned in terms of offering proceeds and regulatory approval, and is approved by the Preferred Majority. 

  
 [Annex A to the Amended
and Restated Shareholders Agreement – Yunji Inc.] 

 “Relevant Period” shall mean in relation to any Founder, the period
during which the Founder is directly or indirectly a shareholder, director, officer and/or employee (either a full-time employee or a part-time employee) and/or has any direct or indirect interest (legal or beneficial) in the capital of any of the
Group Companies. 
 “Restriction Period” shall mean two (2) years after the expiration of the Relevant Period. 

“Restated M&A” shall mean the Second Amended and Restated Memorandum and Articles of Association of the Company in the
form attached as Exhibit A to the Share Purchase Agreement. 
 “SEC” shall mean the U.S. Securities and Exchange
Commission. 
 “Securities Act” shall mean the U.S. Securities Act of 1933, as amended. 

“Series Seed Majority” shall mean the holders holding more than
two-thirds (2/3) of the then outstanding Series Seed Preferred Shares, voting as a single class on an as-converted basis. 

“Series Seed Preferred Shares” shall mean the Company’s Series Seed Preferred Shares, par value US$0.000005 per share.

 “Series A Majority” shall mean the holders holding more than fifty percent (50%) of the then outstanding Series A
Preferred Shares, voting as a single class on an as-converted basis. 
 “Series A Preferred
Shares” shall mean the Series A Preferred Shares of the Company, par value US$0.000005 per share. 
 “Series
B Majority” shall mean the holders holding more than fifty percent (50%) of the then outstanding Series B Preferred Shares and the then outstanding Series B+ Preferred Shares, voting as a single class on an as-converted basis. 
 “Series B Preferred Shares” shall mean the Series B Preferred
Shares of the Company, par value US$0.000005 per share. 
 “Series B+ Preferred Shares” shall mean the Series B+ Preferred
Shares of the Company, par value US$0.000005 per share. 
 “Shareholders” shall mean the Ordinary Shareholders and the
Preferred Shareholders (each a “Shareholder”), unless the text specifically indicates otherwise. 

“Shares” shall mean all Preferred Shares and all Ordinary Shares now owned or subsequently acquired by any shareholder. 

“Smallyes Group Companies” shall mean, collectively, Zhejiang Smallyes Network Technology Co., Ltd. (浙江小也网络科技有限公司), Hangzhou Smallyes Cosmetics Co., Ltd.
(杭州小也化妆品有限公司) and Shanghai Suye Cosmetics Co.,
Ltd. (上海素野化妆品有限公司). 

  
 [Annex A to the Amended
and Restated Shareholders Agreement – Yunji Inc.] 

 “Subsidiary” or “subsidiary” shall mean, with respect to
any subject entity (the “subject entity”), (i) any company, partnership or other entity (x) more than fifty percent (50%) of whose shares or other interests entitled to vote in the election of directors or (y) more than a
fifty percent (50%) interest in the profits or capital of such entity are owned or controlled directly or indirectly by the subject entity or through one (1) or more Subsidiaries of the subject entity, (ii) any entity whose assets, or
portions thereof, are consolidated with the net earnings of the subject entity and are recorded on the books of the subject entity for financial reporting purposes in accordance with IAS or U.S. GAAP, or (iii) any entity with respect to which
the subject entity has the power to otherwise direct the business and policies of that entity directly or indirectly through another subsidiary. Notwithstanding the above, as applied to the Company, the term “Subsidiary” or
“subsidiary” includes the the HK Co., the WFOE, Domestic Co, the PRC Subsidiaries and the HK Subsidiary. 
 “TH
Capital” shall mean China TH Capital Limited. 
 “Trade Sale” shall mean any of the following events: 

(i)     the acquisition of any Group Company (whether by a sale of equity, merger or consolidation) in which in excess of
fifty percent (50%) of such Group Company’s voting power outstanding before such transaction is transferred; 

(ii)    the sale, transfer or other disposition of all or substantially all of the assets, or Intellectual Property of any
Group Company; or 
 (iii)     the exclusive licensing of all or substantially all of any Group Company’s
Intellectual Property rights. 
 “Transaction Documents” shall mean this Agreement, the Share Purchase Agreement, the
Restated M&A, the Resturcturing Agreements, the exhibits attached to any of the foregoing and any other document, certificate, and agreement delivered in connection with the transactions contemplated hereby and thereby. 

“Trustbridge” shall mean, collectively, FASTURN OVERSEAS LIMITED and TRUSTBRIDGE PARTNERS IV, L.P. 

“US$” and “USD” shall mean the lawful currency of the United States of America. 

“U.S. GAAP” shall mean the accounting principles generally accepted in the United States. 

  
 [Annex A to the Amended
and Restated Shareholders Agreement – Yunji Inc.] 

 EXHIBIT A 

PROTECTIVE PROVISIONS 

Part I    Acts of the Group Companies Requiring Approval of Preferred Majority 

In addition to such other restrictions or limitations as may be provided herein or in other Transaction Documents, for so long as any
Preferred Share remains outstanding, each Group Company shall not, and each of the Warrantors (as defined under the Share Purchase Agreement) shall procure each Group Company not to, directly or indirectly, and whether by amendment, merger,
consolidation, scheme of arrangement, amalgamation, or otherwise, take any of the actions listed in this Part I of Exhibit A without the prior written consent of the Preferred Majority. Notwithstanding anything to the contrary
contained herein, where any act listed in this Part I of Exhibit A requires the approval of the Shareholders in accordance with the Statute, and if the Shareholders vote in favour of such act but the approval of the Preferred Majority
has not yet been obtained, the Preferred Shareholders who vote against such act at a meeting of the Shareholders in aggregate shall have the voting rights equal to the aggregate voting power of all the Shareholders who voted in favor of such act
plus one (1). 
  

	 	(a)	 any change to the Restated M&A or other Charter Documents of the Company or any of its Subsidiaries;

  

	 	(b)	 any filing by or against any Group Company for the appointment of a receiver, administrator or other form of
external manager, or the winding up, liquidation, bankruptcy or insolvency of any Group Company; 

  

	 	(c)	 increase, reduce or cancel the authorized or issued share capital of the Company and/or any of its Subsidiaries
or issue, allot, purchase or redeem any shares or securities convertible into or carrying a right of subscription in respect of shares or any share warrants (but excluding any redemption provided under Article 19 of the Restated M&A) or grant or
issue any options rights or warrants of which may require the issue of shares in the future or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Preferred Shares in the Company;

  

	 	(d)	 the consolidation or merger with or into any other business entity or change of control of any Group Company;

  

	 	(e)	 take any action that reclassifies any outstanding shares into shares having preferences or priority as to
dividends or assets senior to or on a parity with the preference of the holders of the Preferred Shares; 

  

	 	(f)	 any Deemed Liquidation Event (but excluding any Drag-Along Sale); 

 

	 	(g)	 the declaration or payment or change of policy of a dividend or other distributions on any securities of any
Group Company; capitalization of the premiums of the Company and/or any of its Subsidiaries; 

  

	 	(h)	 any increase or decrease in the size of the Board; 

	 	(i)	 adopt the annual budget of the Group Companies or any substantial amendment to the business plan or annual
budgets of the Group Companies previously adopted; 

  

	 	(j)	 substantial change to the principle business of the Group Companies; 

 

	 	(k)	 any financing plan by the Group Companies from other investors; and 

 

	 	(l)	 enter into or change arrangements for any public offering of the Company’s or any of its
Subsidiaries’ securities, including the selection of any underwriter, accountant, counsel, and the exchange stock for such offering; approval on the offering or listing scheme, valuation and pre-listing
restructuring plan of the Group Companies. 

  
 [Exhibit A to the Amended
and Restated Shareholders Agreement – Yunji Inc.] 

 Part II    Acts of the Group Companies Requiring Approval of the
Investor Directors 
 In addition to such other restrictions or limitations as may be provided herein or in other Transaction Documents,
for so long as there is any Investor Director, each Group Company shall not, and each of the Warrantors shall procure each Group Company not to, directly or indirectly, and whether by amendment, merger, consolidation, scheme of arrangement,
amalgamation, or otherwise, take any of the actions listed in this Part II of Exhibit A without the prior written consent of all the Investor Directors. Notwithstanding anything to the contrary contained herein, where any act listed in this Part II
of Exhibit A requires the approval of the Board in accordance with the Statute, and if the Board vote in favour of such act but the approval of all the Investor Directors have not yet been obtained, the Investor Directors shall have the voting
rights equal to the aggregate voting power of all the Directors who voted in favor of such act plus one (1). 
  

	 	(a)	 any investment into other company, partnership, trust, joint venture or entity which is in excess of
US$1,000,000 in respect of any one (1) transaction or in related transactions in any fiscal year by the Company and/or any of its Subsidiaries; or establishment of any joint venture with investment amount exceeding US$1,000,000;

  

	 	(b)	 any borrowing beyond the annual budget in excess of US$2,000,000 in respect of any one (1) transaction or
in related transactions in any fiscal year by the Company and/or any of its Subsidiaries other than any short-term financing obtained from banks or other financial institutions in the ordinary course of business; 

 

	 	(c)	 purchase or lease of any assets with value exceeding US$500,000 in a single transaction or series of related
transactions by any Group Company beyond the annual budget of the Group Companies; 

  

	 	(d)	 any related party transaction between any Group Company and any shareholder, director, officer, employee, or
any Affiliate of the foregoing, any Affiliate of any Group Company, or any shareholder, director, officer, employee of any Affiliate of any Group Company, or any other entity in which any Founderholds any euiqyt interest beyond the ordinary course
of business (in respect of any transaction between any Group Company and any Smallyes Group Company, only applicable to any transaction the scope and amount of which substantially differ from those existing as of the date hereof);

  

	 	(e)	 beyond the ordinary course of business, any loan provided by any Group Company to any third party in an amount
exeeding US$1,000,000; or the provision of any guarantee or security for or in connection with any indebtedness of liabilities of any third party (excluding any loan or guarantee existing as of the date hereof); 

 

	 	(f)	 create or issue any debenture constituting a pledge, lien or charge on the material assets (the amount of which
exceeding 5% of the total book value of the Group Companies) of any Group Company; 

  
 [Exhibit A to the Amended
and Restated Shareholders Agreement – Yunji Inc.] 

	 	(g)	 sell, transfer or dispose of material assets (the amount of which exceeding 5% of the total book value of the
Group Companies) or business of any Group Company; 

  

	 	(h)	 sell, transfer, license, charge, encumber or otherwise dispose of any material technology or material
trademarks, patents, copyrights or other intellectual property owned by any Group Company (exluding any technology license necessary in the ordinary course of business); 

 

	 	(i)	 sale, transfer, dispose of or dilute the Company’s interest, directly or indirectly, in any of its
Subsidiaries; or approval on the equity transfer of any Subsidary; 

  

	 	(j)	 any adoption, amendment or termination of any bonus or profit sharing scheme, including any employee share
option or share participation scheme or any employee incentive scheme, but excluding the ESOP provided under Section 10.4 in connection with 191,663,158 Ordinary Shares and corresponding options; 

 

	 	(k)	 appoint or dismissal of the chief executive officer and chief financial officer of the Company and/or any of
its Subsidiaries; 

  

	 	(l)	 raise, withdraw, settler or reconcile any claim in relation to dispute involving more than US$1,000,000; and

  

	 	(m)	 appoint or change the auditors of the Company and/or any of its Subsidiaries; or substantial change to the
accounting policy of the Company and/or any of its Subsidiaries. 

  
 [Exhibit A to the Amended
and Restated Shareholders Agreement – Yunji Inc.]EX-10.1

 Exhibit 10.1 

Yunji Inc. 
 2019 Share
Incentive Plan 
 ARTICLE 1 

PURPOSE 
 The purpose of
the Plan is to promote the success and enhance the value of Yunji Inc., an exempted company formed under the laws of the Cayman Islands (the “Company”), by linking the personal interests of the Directors, Employees, and Consultants
to those of the Company’s shareholders and by providing such individuals with an incentive for outstanding performance to generate superior returns to the Company’s shareholders. The Plan amends and restates the previously adopted 2017
Share Incentive Plan of the Company in its entirety and assumes all awards granted under the 2017 Share Incentive Plan. 
 ARTICLE 2

 DEFINITIONS AND CONSTRUCTION 

Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates
otherwise. The singular pronoun shall include the plural where the context so indicates. 
 2.1    “Applicable
Laws” means the legal requirements relating to the Plan and the Awards under applicable provisions of the corporate, securities, tax and other laws, rules, regulations and government orders, and the rules of any applicable stock exchange or
national market system, of any jurisdiction applicable to Awards granted to residents therein.

2.2    “Award” means an Option, Restricted Share, Restricted Share Units or other types of award approved
by the Committee granted to a Participant pursuant to the Plan. 
 2.3    “Award Agreement” means any
written agreement, contract, or other instrument or document evidencing an Award, including through electronic medium. 

2.4    “Board” means the Board of Directors of the Company. 

2.5    “Cause” with respect to a Participant means (unless otherwise expressly provided in the applicable
Award Agreement, or another applicable contract with the Participant that defines such term for purposes of determining the effect that a “for cause” termination has on the Participant’s Awards) a termination of employment or service
based upon a finding by the Service Recipient, acting in good faith and based on its reasonable belief at the time, that the Participant: 

(a)    has been negligent in the discharge of his or her duties to the Service Recipient, has refused to perform stated or
assigned duties or is incompetent in or (other than by reason of a disability or analogous condition) incapable of performing those duties; 

  
 1 

 (b)    has been dishonest or committed or engaged in an act of theft,
embezzlement or fraud, a breach of confidentiality, an unauthorized disclosure or use of inside information, customer lists, trade secrets or other confidential information; 

(c)    has breached a fiduciary duty, or willfully and materially violated any other duty, law, rule, regulation or policy
of the Service Recipient; or has been convicted of, or plead guilty or nolo contendere to, a felony or misdemeanor (other than minor traffic violations or similar offenses); 

(d)    has materially breached any of the provisions of any agreement with the Service Recipient; 

(e)    has engaged in unfair competition with, or otherwise acted intentionally in a manner injurious to the reputation,
business or assets of, the Service Recipient; or 
 (f)    has improperly induced a vendor or customer to break or
terminate any contract with the Service Recipient or induced a principal for whom the Service Recipient acts as agent to terminate such agency relationship. 

A termination for Cause shall be deemed to occur (subject to reinstatement upon a contrary final determination by the Committee) on the date
on which the Service Recipient first delivers written notice to the Participant of a finding of termination for Cause. 

2.6    “Code” means the Internal Revenue Code of 1986 of the United States, as amended. 

2.7     “Committee” means a committee of the Board described in Article 10. 

2.8     “Consultant” means any consultant or adviser if: (a) the consultant or adviser renders bona
fide services to a Service Recipient; (b) the services rendered by the consultant or adviser are not in connection with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a
market for the Company’s securities; and (c) the consultant or adviser is a natural person who has contracted directly with the Service Recipient to render such services. 

2.9     “Corporate Transaction”, unless otherwise defined in an Award Agreement, means any of the
following transactions, provided, however, that the Committee shall determine under (d) and (e) whether multiple transactions are related, and its determination shall be final, binding and conclusive: 

(a)    an amalgamation, arrangement or consolidation or scheme of arrangement (i) in which the Company is not the
surviving entity, except for a transaction the principal purpose of which is to change the jurisdiction in which the Company is incorporated or (ii) following which the holders of the voting securities of the Company do not continue to hold
more than 50% of the combined voting power of the voting securities of the surviving entity; 
 (b)    the sale,
transfer or other disposition of all or substantially all of the assets of the Company; 

  
 2 

 (c)    the complete liquidation or dissolution of the Company; 

(d)    any reverse takeover or series of related transactions culminating in a reverse takeover (including, but not
limited to, a tender offer followed by a reverse takeover) in which the Company is the surviving entity but (A) the Company’s equity securities outstanding immediately prior to such takeover are converted or exchanged by virtue of the
takeover into other property, whether in the form of securities, cash or otherwise, or (B) in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities are
transferred to a person or persons different from those who held such securities immediately prior to such takeover or the initial transaction culminating in such takeover, but excluding any such transaction or series of related transactions that
the Committee determines shall not be a Corporate Transaction; or 
 (e)    acquisition in a single or series of related
transactions by any person or related group of persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of
securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities but excluding any such transaction or series of related transactions that the Committee determines shall not be a
Corporate Transaction. 
 2.10    “Director”, means a member of the Board or a member of the board of
directors of any Subsidiary of the Company. 
 2.11     “Disability”, unless otherwise defined in an
Award Agreement, means that the Participant qualifies to receive long-term disability payments under the Service Recipient’s long-term disability insurance program, as it may be amended from time to time, to which the Participant provides
services regardless of whether the Participant is covered by such policy. If the Service Recipient to which the Participant provides service does not have a long-term disability plan in place, “Disability” means that a Participant is
unable to carry out the responsibilities and functions of the position held by the Participant by reason of any medically determinable physical or mental impairment for a period of not less than ninety (90) consecutive days. A Participant will
not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy the Committee in its discretion. 

2.12    “Effective Date” shall have the meaning set forth in Section 11.1. 

2.13    “Employee” means any person, including an officer or a Director, who is in the employment of a
Service Recipient, subject to the control and direction of the Service Recipient as to both the work to be performed and the manner and method of performance. The payment of a director’s fee by a Service Recipient shall not be sufficient to
constitute “employment” by the Service Recipient. 
 2.14    “Exchange Act” means the
Securities Exchange Act of 1934 of the United States, as amended. 

  
 3 

 2.15    “Fair Market Value” means, as of any date, the
value of Shares determined as follows: 
 (a)    If the Shares are listed on one or more established stock exchanges or
national market systems, including without limitation, the New York Stock Exchange or the NASDAQ Stock Market, its Fair Market Value shall be the closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on the
principal exchange or system on which the Shares are listed (as determined by the Committee) on the date of determination (or, if no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing
sales price or closing bid was reported), as reported on the website maintained by such exchange or market system or such other source as the Committee deems reliable; or 

(b)    In the absence of an established market for the Shares of the type described in (a) above, the Fair Market
Value thereof shall be determined by the Committee in good faith and in its discretion by reference to (i) the placing price of the latest private placement of the Shares and the development of the Company’s business operations and the
general economic and market conditions since such latest private placement, (ii) other third party transactions involving the Shares and the development of the Company’s business operation and the general economic and market conditions
since such transaction, (iii) an independent valuation of the Shares, or (iv) such other methodologies or information as the Committee determines to be indicative of Fair Market Value. 

2.16    “Group Entity” means any of the Company and Subsidiaries of the Company. 

2.17    “Incentive Share Option” means an Option that is intended to meet the requirements of
Section 422 of the Code or any successor provision thereto. 
 2.18    “Independent Director”
means (i) if the Shares or other securities representing the Shares are not listed on a stock exchange, a Director of the Company who is a Non-Employee Director; and (ii) if the Shares or other
securities representing the Shares are listed on one or more stock exchange, a Director of the Company who meets the independence standards under the applicable corporate governance rules of the stock exchange(s). 

2.19    “Non-Employee Director” means a member of the Board who
qualifies as a “Non-Employee Director” as defined in Rule 16b-3(b)(3) of the Exchange Act, or any successor definition adopted by the Board. 

2.20    “Non-Qualified Share Option” means an Option that is not
intended to be an Incentive Share Option. 
 2.21    “Option” means a right granted to a Participant
pursuant to Article 5 of the Plan to purchase a specified number of Shares at a specified price during specified time periods. An Option may be either an Incentive Share Option or a Non-Qualified Share Option.

 2.22    “Participant” means a person who, as a Director, Consultant or Employee, has been granted an
Award pursuant to the Plan. 
 2.23    “Parent” means a parent corporation under Section 424(e) of
the Code. 
 2.24    “Plan” means this 2019 Share Incentive Plan of Yunji Inc., as amended and/or
restated from time to time. 

  
 4 

 2.25    “Related Entity” means any business,
corporation, partnership, limited liability company or other entity in which the Company, a Parent or Subsidiary of the Company holds a substantial ownership interest, directly or indirectly, or controls through contractual arrangements and
consolidates the financial results according to applicable accounting standards, but which is not a Subsidiary and which the Board designates as a Related Entity for purposes of the Plan. 

2.26    “Restricted Share” means a Share awarded to a Participant pursuant to Article 6 that is subject
to certain restrictions and may be subject to risk of forfeiture. 
 2.27    “Restricted Share Unit”
means the right granted to a Participant pursuant to Article 7 to receive a Share at a future date. 

2.28    “Securities Act” means the Securities Act of 1933 of the United States, as amended. 

2.29    “Service Recipient” means the Company or Subsidiary of the Company to which a Participant
provides services as an Employee, a Consultant or a Director. 
 2.30    “Share” means the ordinary
shares of the Company, par value US$0.000005 per share, and such other securities of the Company that may be substituted for Shares pursuant to Article 9. 

2.31    “Subsidiary” means any corporation or other entity of which a majority of the outstanding voting
shares or voting power is beneficially owned directly or indirectly by the Company. 
 2.32    “Trading
Date” means the closing of the first sale to the general public of the Shares pursuant to a registration statement filed with and declared effective by the U.S. Securities and Exchange Commission under the Securities Act. 

ARTICLE 3 
 SHARES
SUBJECT TO THE PLAN 
 3.1    Number of Shares. 

(a)    Subject to the provisions of Article 9 and Section 3.1(b), the maximum aggregate number of Shares which may be
issued pursuant to all Awards (including Incentive Share Options) (the “Award Pool”) shall initially be 227,401,861 Shares, which shall be increased by a number equal to 1% of the then total issued and outstanding Shares on an as-converted fully diluted basis, on each of the first, second, third, fourth and fifth anniversary of the Effective Date. 

  
 5 

 (b)    To the extent that an Award terminates, expires, or lapses for
any reason, any Shares subject to the Award shall again be available for the grant of an Award pursuant to the Plan. To the extent permitted by Applicable Laws, Shares issued in assumption of, or in substitution for, any outstanding awards of any
entity acquired in any form or combination by a Group Entity shall not be counted against Shares available for grant pursuant to the Plan. Shares delivered by the Participant or withheld by the Company upon the exercise of any Award under the Plan,
in payment of the exercise price thereof or tax withholding thereon, may again be optioned, granted or awarded hereunder, subject to the limitations of Section 3.1(a). If any Restricted Shares are forfeited by the Participant or repurchased by
the Company, such Shares may again be optioned, granted or awarded hereunder, subject to the limitations of Section 3.1(a). Notwithstanding the provisions of this Section 3.1(b), no Shares may again be optioned, granted or awarded if such
action would cause an Incentive Share Option to fail to qualify as an incentive share option under Section 422 of the Code. 

3.2    Shares Distributed. Any Shares distributed pursuant to an Award may consist, in whole or in part, of
authorized and unissued Shares, treasury Shares (subject to Applicable Laws) or Shares purchased on the open market. Additionally, at the discretion of the Committee, any Shares distributed pursuant to an Award may be represented by American
Depository Shares. If the number of Shares represented by an American Depository Share is other than on a one-to-one basis, the limitations of Section 3.1 shall be
adjusted to reflect the distribution of American Depository Shares in lieu of Shares. 
 ARTICLE 4 

ELIGIBILITY AND PARTICIPATION 

4.1    Eligibility. Persons eligible to participate in this Plan include Employees, Consultants, and Directors, as
determined by the Committee. 
 4.2    Participation. Subject to the provisions of the Plan, the Committee may,
from time to time, select from among all eligible individuals, those to whom Awards shall be granted and shall determine the nature and amount of each Award. No individual shall have any right to be granted an Award pursuant to this Plan. 

ARTICLE 5 
 OPTIONS

 5.1    General. The Committee is authorized to grant Options to Participants on the following terms and
conditions: 
 (a)    Exercise Price. The exercise price per Share subject to an Option shall be determined by
the Committee and set forth in the Award Agreement which may be a fixed price or a variable price related to the Fair Market Value of the Shares. The exercise price per Share subject to an Option may be amended or adjusted in the absolute discretion
of the Committee, the determination of which shall be final, binding and conclusive. For the avoidance of doubt, to the extent not prohibited by Applicable Laws or any exchange rule, a downward adjustment of the exercise prices of Options mentioned
in the preceding sentence shall be effective without the approval of the Company’s shareholders or the approval of the affected Participants. 

  
 6 

 (b)    Time and Conditions of Exercise. The Committee shall
determine the time or times at which an Option may be exercised in whole or in part, including exercise prior to vesting; provided that the term of any Option granted under the Plan shall not exceed ten years, except as provided in
Section 12.1. The Committee shall also determine any conditions, if any, that must be satisfied before all or part of an Option may be exercised. 

(c)    Payment. The Committee shall determine the methods by which the exercise price of an Option may be paid, the
form of payment, including, without limitation (i) cash or check denominated in U.S. Dollars, (ii) to the extent permissible under the Applicable Laws, cash or check in Chinese Renminbi, (iii) cash or check denominated in any other
local currency as approved by the Committee, (iv) Shares held for such period of time as may be required by the Committee in order to avoid adverse financial accounting consequences and having a Fair Market Value on the date of delivery equal
to the aggregate exercise price of the Option or exercised portion thereof, (v) after the Trading Date the delivery of a notice that the Participant has placed a market sell order with a broker with respect to Shares then issuable upon exercise
of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the Option exercise price; provided that payment of such proceeds is then made to the Company upon
settlement of such sale, (vi) other property acceptable to the Committee with a Fair Market Value equal to the exercise price, or (vii) any combination of the foregoing. Notwithstanding any other provision of the Plan to the contrary, no
Participant who is a member of the Board or an “executive officer” of the Company within the meaning of Section 13(k) of the Exchange Act shall be permitted to pay the exercise price of an Option in any method which would violate
Section 13(k) of the Exchange Act. 
 (d)    Effects of Termination of Employment or Service on Options.
Termination of employment or service shall have the following effects on Options granted to the Participants: 

(i)    Dismissal for Cause. Unless otherwise provided in the Award Agreement, if a Participant’s employment
by or service to the Service Recipient is terminated by the Service Recipient for Cause, the Participant’s Options will terminate upon such termination, whether or not the Option is then vested and/or exercisable; 

(ii)    Death or Disability. Unless otherwise provided in the Award Agreement, if a Participant’s employment
by or service to the Service Recipient terminates as a result of the Participant’s death or Disability: 
  

	 	(a)	 the Participant (or his or her legal representative or beneficiary, in the case of the Participant’s
Disability or death, respectively), will have until the date that is 12 months after the Participant’s termination of Employment to exercise the Participant’s Options (or portion thereof) to the extent that such Options were vested and
exercisable on the date of the Participant’s termination of Employment on account of death or Disability; 

  

	 	(b)	 the Options, to the extent not vested and exercisable on the date of the Participant’s termination of
Employment or service, shall terminate upon the Participant’s termination of Employment or service on account of death or Disability; and 

  
 7 

	 	(c)	 the Options, to the extent exercisable for the 12-month period
following the Participant’s termination of Employment or service and not exercised during such period, shall terminate at the close of business on the last day of the 12-month period.

 (iii)    Other Terminations of Employment or Service. Unless otherwise provided in the
Award Agreement, if a Participant’s employment by or service to the Service Recipient terminates for any reason other than a termination by the Service Recipient for Cause or because of the Participant’s death or Disability: 

 

	 	(a)	 the Participant will have until the date that is 90 days after the Participant’s termination of Employment
or service to exercise his or her Options (or portion thereof) to the extent that such Options were vested and exercisable on the date of the Participant’s termination of Employment or service; 

 

	 	(b)	 the Options, to the extent not vested and exercisable on the date of the Participant’s termination of
Employment or service, shall terminate upon the Participant’s termination of Employment or service; and 

  

	 	(c)	 the Options, to the extent exercisable for the 90-day period following
the Participant’s termination of Employment or service and not exercised during such period, shall terminate at the close of business on the last day of the 90-day period. 

5.2    Incentive Share Options. Incentive Share Options may be granted to Employees of the Company or a Subsidiary
of the Company. Incentive Share Options may not be granted to employees of a Related Entity or to Independent Directors or Consultants. The terms of any Incentive Share Options granted pursuant to the Plan, in addition to the requirements of
Section 5.1, must comply with the following additional provisions of this Section 5.2: 
 (a)    Individual
Dollar Limitation. The aggregate Fair Market Value (determined as of the time the Option is granted) of all Shares with respect to which Incentive Share Options are first exercisable by a Participant in any calendar year may not exceed $100,000
or such other limitation as imposed by Section 422(d) of the Code, or any successor provision. To the extent that Incentive Share Options are first exercisable by a Participant in excess of such limitation, the excess shall be considered Non-Qualified Share Options. 
 (b)    Exercise Price. The exercise price of an
Incentive Share Option shall be equal to the Fair Market Value on the date of grant. However, the exercise price of any Incentive Share Option granted to any individual who, at the date of grant, owns Shares possessing more than ten percent of the
total combined voting power of all classes of shares of the Company or any Parent or Subsidiary of the Company may not be less than 110% of Fair Market Value on the date of grant and such Option may not be exercisable for more than five years from
the date of grant. 

  
 8 

 (c)    Transfer Restriction. The Participant shall give the
Company prompt notice of any disposition of Shares acquired by exercise of an Incentive Share Option within (i) two years from the date of grant of such Incentive Share Option or (ii) one year after the transfer of such Shares to the
Participant. 
 (d)    Expiration of Incentive Share Options. No Award of an Incentive Share Option may be made
pursuant to this Plan after the tenth anniversary of the Effective Date. 
 (e)    Right to Exercise. During a
Participant’s lifetime, an Incentive Share Option may be exercised only by the Participant. 
 ARTICLE 6 

RESTRICTED SHARES 

6.1    Grant of Restricted Shares. The Committee, at any time and from time to time, may grant Restricted Shares to
Participants as the Committee, in its sole discretion, shall determine. The Committee, in its sole discretion, shall determine the number of Restricted Shares to be granted to each Participant. 

6.2    Restricted Shares Award Agreement. Each Award of Restricted Shares shall be evidenced by an Award Agreement
that shall specify the period of restriction, the number of Restricted Shares granted, and such other terms and conditions as the Committee, in its sole discretion, shall determine. Unless the Committee determines otherwise, Restricted Shares shall
be held by the Company as escrow agent until the restrictions on such Restricted Shares have lapsed. 

6.3    Issuance and Restrictions. Restricted Shares shall be subject to such restrictions on transferability and
other restrictions as the Committee may impose (including, without limitation, limitations on the right to vote Restricted Shares or the right to receive dividends on the Restricted Shares). These restrictions may lapse separately or in combination
at such times, pursuant to such circumstances, in such installments, or otherwise, as the Committee determines at the time of the grant of the Award or thereafter. 

6.4    Forfeiture/Repurchase. Except as otherwise determined by the Committee at the time of the grant of the Award
or thereafter, upon termination of employment or service during the applicable restriction period, Restricted Shares that are at that time subject to restrictions shall be forfeited or repurchased in accordance with the Award Agreement; provided,
however, the Committee may (a) provide in any Restricted Share Award Agreement that restrictions or forfeiture and repurchase conditions relating to Restricted Shares will be waived in whole or in part in the event of terminations resulting
from specified causes, and (b) in other cases waive in whole or in part restrictions or forfeiture and repurchase conditions relating to Restricted Shares. 

6.5    Certificates for Restricted Shares. Restricted Shares granted pursuant to the Plan may be evidenced in such
manner as the Committee shall determine. If certificates representing Restricted Shares are registered in the name of the Participant, certificates must bear an appropriate legend referring to the terms, conditions, and restrictions applicable to
such Restricted Shares, and the Company may, at its discretion, retain physical possession of the certificate until such time as all applicable restrictions lapse. 

  
 9 

 6.6    Removal of Restrictions. Except as otherwise provided in
this Article 6, Restricted Shares granted under the Plan shall be released from escrow as soon as practicable after the last day of the period of restriction. The Committee, in its discretion, may accelerate the time at which any restrictions shall
lapse or be removed. After the restrictions have lapsed, the Participant shall be entitled to have any legend or legends under Section 6.5 removed from his or her Share certificate, and the Shares shall be freely transferable by the
Participant, subject to applicable legal restrictions. The Committee (in its discretion) may establish procedures regarding the release of Shares from escrow and the removal of legends, as necessary or appropriate to minimize administrative burdens
on the Company. 
 ARTICLE 7 

7.1    Grant of Restricted Share Units. The Committee, at any time and from time to time, may grant Restricted
Share Units to Participants as the Committee, in its sole discretion, shall determine. The Committee, in its sole discretion, shall determine the number of Restricted Share Units to be granted to each Participant. 

7.2    Restricted Share Units Award Agreement. Each Award of Restricted Share Units shall be evidenced by an Award
Agreement that shall specify any vesting conditions, the number of Restricted Share Units granted, and such other terms and conditions as the Committee, in its sole discretion, shall determine. 

7.3    Form and Timing of Payment of Restricted Share Units. At the time of grant, the Committee shall specify the
date or dates on which the Restricted Share Units shall become fully vested and nonforfeitable. Upon vesting, the Committee, in its sole discretion, may pay Restricted Share Units in the form of cash, Shares or a combination thereof. 

7.4    Forfeiture/Repurchase. Except as otherwise determined by the Committee at the time of the grant of the Award
or thereafter, upon termination of employment or service during the applicable restriction period, Restricted Share Units that are at that time unvested shall be forfeited or repurchased in accordance with the Award Agreement; provided,
however, the Committee may (a) provide in any Restricted Share Unit Award Agreement that restrictions or forfeiture and repurchase conditions relating to Restricted Share Units will be waived in whole or in part in the event of terminations
resulting from specified causes, and (b) in other cases waive in whole or in part restrictions or forfeiture and repurchase conditions relating to Restricted Share Units. 

ARTICLE 8 
 PROVISIONS
APPLICABLE TO AWARDS 
 8.1    Award Agreement. Awards under the Plan shall be evidenced by Award Agreements
that set forth the terms, conditions and limitations for each Award which may include the term of an Award, the provisions applicable in the event the Participant’s employment or service terminates, and the Company’s authority to
unilaterally or bilaterally amend, modify, suspend, cancel or rescind an Award. 

  
 10 

 8.2    No Transferability; Limited Exception to Transfer
Restrictions. 
 8.2.1 Limits on Transfer. Unless otherwise expressly provided in (or pursuant to) this Section 8.2,
by applicable law and by the Award Agreement, as the same may be amended: 
 (a)    all Awards are non-transferable and will not be subject in any manner to sale, transfer, anticipation, alienation, assignment, pledge, encumbrance or charge; 

(b)    Awards will be exercised only by the Participant; and 

(c)    amounts payable or shares issuable pursuant to an Award will be delivered only to (or for the account of), and, in
the case of Shares, registered in the name of, the Participant. 
 In addition, the shares shall be subject to the restrictions set forth in
the applicable Award Agreement. 
 8.2.2    Further Exceptions to Limits on Transfer. The exercise and transfer
restrictions in Section 8.2.1 will not apply to: 
 (a)    transfers to the Company or a Subsidiary; 

(b)    transfers by gift to “immediate family” as that term is defined in SEC Rule 16a-1(e) promulgated under the Exchange Act; 
 (c)    the designation of a
beneficiary to receive benefits if the Participant dies or, if the Participant has died, transfers to or exercises by the Participant’s beneficiary, or, in the absence of a validly designated beneficiary, transfers by will or the laws of
descent and distribution; or 
 (d)    if the Participant has suffered a disability, permitted transfers or exercises on
behalf of the Participant by the Participant’s duly authorized legal representative; or 
 (e)    subject to the
prior approval of the Committee or an executive officer or director of the Company authorized by the Committee, transfer to one or more natural persons who are the Participant’s family members or entities owned and controlled by the Participant
and/or the Participant’s family members, including but not limited to trusts or other entities whose beneficiaries or beneficial owners are the Participant and/or the Participant’s family members, or to such other persons or entities as
may be expressly approved by the Committee, pursuant to such conditions and procedures as the Committee or may establish. Any permitted transfer shall be subject to the condition that the Committee receives evidence satisfactory to it that the
transfer is being made for estate and/or tax planning purposes and on a basis consistent with the Company’s lawful issue of securities. 

  
 11 

 Notwithstanding anything else in this Section 8.2.2 to the contrary, but subject to
compliance with all Applicable Laws, Incentive Share Options, Restricted Shares and Restricted Share Units will be subject to any and all transfer restrictions under the Code applicable to such Awards or necessary to maintain the intended tax
consequences of such Awards. Notwithstanding clause (b) above but subject to compliance with all Applicable Laws, any contemplated transfer by gift to “immediate family” as referenced in clause (b) above is subject to the
condition precedent that the transfer be approved by the Administrator in order for it to be effective. 

8.3    Beneficiaries. Notwithstanding Section 8.2, a Participant may, in the manner determined by the
Committee, designate a beneficiary to exercise the rights of the Participant and to receive any distribution with respect to any Award upon the Participant’s death. A beneficiary, legal guardian, legal representative, or other person claiming
any rights pursuant to the Plan is subject to all terms and conditions of the Plan and any Award Agreement applicable to the Participant, except to the extent the Plan and Award Agreement otherwise provide, and to any additional restrictions deemed
necessary or appropriate by the Committee. If the Participant is married and resides in a community property state, a designation of a person other than the Participant’s spouse as his or her beneficiary with respect to more than 50% of the
Participant’s interest in the Award shall not be effective without the prior written consent of the Participant’s spouse. If no beneficiary has been designated or survives the Participant, payment shall be made to the person entitled
thereto pursuant to the Participant’s will or the laws of descent and distribution. Subject to the foregoing, a beneficiary designation may be changed or revoked by a Participant at any time provided the change or revocation is filed with the
Committee. 
 8.4    Performance Objectives and Other Terms. The Committee, in its discretion, shall set
performance objectives or other vesting criteria which, depending on the extent to which they are met, will determine the number or value of the Awards that will be granted or paid out to the Participants. 

ARTICLE 9 
 CHANGES IN
CAPITAL STRUCTURE 
 9.1    Adjustments. In the event of any dividend, share split, combination or exchange
of Shares, amalgamation, arrangement or consolidation, spin-off, recapitalization or other distribution (other than normal cash dividends) of Company assets to its shareholders, or any other change affecting
the shares of Shares or the share price of a Share, the Committee shall make such proportionate adjustments, if any, as the Committee in its discretion may deem appropriate to reflect such change with respect to (a) the aggregate number and
type of shares that may be issued under the Plan (including, but not limited to, adjustments of the limitations in Section 3.1); (b) the terms and conditions of any outstanding Awards (including, without limitation, any applicable performance
targets or criteria with respect thereto); and (c) the grant or exercise price per share for any outstanding Awards under the Plan. 

  
 12 

 9.2    Corporate Transactions. Except as may otherwise be
provided in any Award Agreement or any other written agreement entered into by and between the Company and a Participant, if the Committee anticipates the occurrence, or upon the occurrence, of a Corporate Transaction, the Committee may, in its sole
discretion, provide for (i) any and all Awards outstanding hereunder to terminate at a specific time in the future and shall give each Participant the right to exercise the vested portion of such Awards during a period of time as the Committee
shall determine, or (ii) the purchase of any Award for an amount of cash equal to the amount that could have been attained upon the exercise of such Award (and, for the avoidance of doubt, if as of such date the Committee determines in good
faith that no amount would have been attained upon the exercise of such Award, then such Award may be terminated by the Company without payment), or (iii) the replacement of such Award with other rights or property selected by the Committee in
its sole discretion or the assumption of or substitution of such Award by the successor or surviving corporation, or a Parent or Subsidiary thereof, with appropriate adjustments as to the number and kind of Shares and prices, or (iv) payment of
such Award in cash based on the value of Shares on the date of the Corporate Transaction plus reasonable interest on the Award through the date as determined by the Committee when such Award would otherwise be vested or have been paid in accordance
with its original terms, if necessary to comply with Section 409A of the Code. 
 9.3    Outstanding Awards
– Other Changes. In the event of any other change in the capitalization of the Company or corporate change other than those specifically referred to in this Article 9, the Committee may, in its absolute discretion, make such adjustments in
the number and class of shares subject to Awards outstanding on the date on which such change occurs and in the per share grant or exercise price of each Award as the Committee may consider appropriate to prevent dilution or enlargement of rights.

 9.4    No Other Rights. Except as expressly provided in the Plan, no Participant shall have any rights by
reason of any subdivision or consolidation of Shares of any class, the payment of any dividend, any increase or decrease in the number of shares of any class or any dissolution, liquidation, merger, or consolidation of the Company or any other
corporation. Except as expressly provided in the Plan or pursuant to action of the Committee under the Plan, and no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment
by reason thereof shall be made with respect to, the number of Shares subject to an Award or the grant or exercise price of any Award. 

ARTICLE 10 

ADMINISTRATION 

10.1    Committee. The Plan shall be administered by the Board or a committee of one or more members of the Board
(the “Committee”) to whom the Board shall delegate the authority to grant or amend Awards to Participants other than any of the Committee members, Independent Directors and executive officers of the Company. Reference to the
Committee shall refer to the Board in absence of the Committee. Notwithstanding the foregoing, the full Board, acting by majority of its members in office, shall conduct the general administration of the Plan if required by Applicable Laws, and with
respect to Awards granted to the Committee members, Independent Directors and executive officers of the Company and for purposes of such Awards the term “Committee” as used in the Plan shall be deemed to refer to the Board. 

  
 13 

 10.2    Action by the Committee. A majority of the Committee
shall constitute a quorum. The acts of a majority of the members present at any meeting at which a quorum is present, and acts approved unanimously in writing all members of the Committee in lieu of a meeting, shall be deemed the acts of the
Committee. Each member of the Committee is entitled to, in good faith, rely or act upon any report or other information furnished to that member by any officer or other employee of a Group Entity, the Company’s independent certified public
accountants, or any executive compensation consultant or other professional retained by the Company to assist in the administration of the Plan. 

10.3    Authority of the Committee. Subject to any specific designation in the Plan, the Committee has the
exclusive power, authority and discretion to: 
 (a)    designate Participants to receive Awards; 

(b)    determine the type or types of Awards to be granted to each Participant; 

(c)    determine the number of Awards to be granted and the number of Shares to which an Award will relate; 

(d)    determine the terms and conditions of any Award granted pursuant to the Plan, including, but not limited to, the
exercise price, grant price, or purchase price, any restrictions or limitations on the Award, any schedule for lapse of forfeiture restrictions or restrictions on the exercisability of an Award, and accelerations or waivers thereof, and any
provisions related to non-competition and recapture of gain on an Award, based in each case on such considerations as the Committee in its sole discretion determines; 

(e)    determine whether, to what extent, and pursuant to what circumstances an Award may be settled in, or the exercise
price of an Award may be paid in, cash, Shares, other Awards, or other property, or an Award may be canceled, forfeited, or surrendered; 

(f)    prescribe the form of each Award Agreement, which need not be identical for each Participant; 

(g)    decide all other matters that must be determined in connection with an Award; 

(h)    establish, adopt, or revise any rules and regulations as it may deem necessary or advisable to administer the Plan;

 (i)    interpret the terms of, and any matter arising pursuant to, the Plan or any Award Agreement; 

(j)    amend terms and conditions of Award Agreements; and 

(k)    make all other decisions and determinations that may be required pursuant to the Plan or as the Committee deems
necessary or advisable to administer the Plan, including design and adopt from time to time new types of Awards that are in compliance with Applicable Laws. 

  
 14 

 10.4    Decisions Binding. The Committee’s interpretation of
the Plan, any Awards granted pursuant to the Plan, any Award Agreement and all decisions and determinations by the Committee with respect to the Plan are final, binding, and conclusive on all parties. 

ARTICLE 11 
 EFFECTIVE
AND EXPIRATION DATE 
 11.1    Effective Date. The Plan shall become effective as of the date it is adopted
and approved by the Board (the “Effective Date”). 
 11.2    Replacement of Original Plan. The
Plan shall replace the previously adopted 2017 Share Incentive Plan in its entirety, and the 2017 Share Incentive Plan shall cease to be effective upon the Effective Date. The Awards granted and outstanding under the 2017 Share Incentive Plan and
the evidencing original Award Agreements shall survive the termination of the 2017 Share Incentive Plan and remain effective and binding under the Plan, subject to any amendment and modification to the original Award Agreements that the Committee,
in its sole discretion, shall determine. 
 11.3    Expiration Date. The Plan will expire on, and no Award may be
granted pursuant to the Plan after, the tenth anniversary of the Effective Date. Any Awards that are outstanding on the tenth anniversary of the Effective Date shall remain in force according to the terms of the Plan and the applicable Award
Agreement. 
 ARTICLE 12 

AMENDMENT, MODIFICATION, AND TERMINATION 

12.1    Amendment, Modification, and Termination. At any time and from time to time, the Board may terminate, amend
or modify the Plan; provided, however, that (a) to the extent necessary and desirable to comply with Applicable Laws or stock exchange rules, the Company shall obtain shareholder approval of any Plan amendment in such a manner and to such a
degree as required, unless the Company decides to follow home country practice, and (b) unless the Company decides to follow home country practice, shareholder approval is required for any amendment to the Plan that (i) increases the
number of Shares available under the Plan (other than any adjustment as provided by Article 9 or Section 3.1(a)), or (ii) permits the Committee to extend the term of the Plan or the exercise period for an Option beyond ten years from the
date of grant. 
 12.2    Awards Previously Granted. Except with respect to amendments made pursuant to
Section 12.1, no termination, amendment, or modification of the Plan shall adversely affect in any material way any Award previously granted pursuant to the Plan without the prior written consent of the Participant. 

  
 15 

 ARTICLE 13 

GENERAL PROVISIONS 

13.1    No Rights to Awards. No Participant, employee, or other person shall have any claim to be granted any Award
pursuant to the Plan, and neither the Company nor the Committee is obligated to treat Participants, employees, and other persons uniformly. 

13.2    No Shareholders Rights. No Award gives the Participant any of the rights of a shareholder of the Company
unless and until Shares are in fact issued to such person in connection with such Award. 
 13.3    Taxes. No
Shares shall be delivered under the Plan to any Participant until such Participant has made arrangements acceptable to the Committee for the satisfaction of any income and employment tax withholding obligations under Applicable Laws. The Company or
any Subsidiary shall have the authority and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy all applicable taxes (including the Participant’s payroll tax obligations) required
or permitted by Applicable Laws to be withheld with respect to any taxable event concerning a Participant arising as a result of this Plan. The Committee may in its discretion and in satisfaction of the foregoing requirement allow a Participant to
elect to have the Company withhold Shares otherwise issuable under an Award (or allow the return of Shares) having a Fair Market Value equal to the sums required to be withheld. Notwithstanding any other provision of the Plan, the number of Shares
which may be withheld with respect to the issuance, vesting, exercise or payment of any Award (or which may be repurchased from the Participant of such Award after such Shares were acquired by the Participant from the Company) in order to satisfy
any income and payroll tax liabilities applicable to the Participant with respect to the issuance, vesting, exercise or payment of the Award shall, unless specifically approved by the Committee, be limited to the number of Shares which have a Fair
Market Value on the date of withholding or repurchase equal to the aggregate amount of such liabilities based on the minimum statutory withholding rates for the applicable income and payroll tax purposes that are applicable to such supplemental
taxable income. 
 13.4    No Right to Employment or Services. Nothing in the Plan or any Award Agreement shall
interfere with or limit in any way the right of the Service Recipient to terminate any Participant’s employment or services at any time, nor confer upon any Participant any right to continue in the employment or services of any Service
Recipient. 
 13.5    Unfunded Status of Awards. The Plan is intended to be an “unfunded” plan for
incentive compensation. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give the Participant any rights that are greater than those of a general creditor of
the relevant Group Entity. 

  
 16 

 13.6    Indemnification. To the extent allowable pursuant to
Applicable Laws, each member of the Committee or of the Board shall be indemnified and held harmless by the Company from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by such member in connection with or
resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action or failure to act pursuant to the Plan and against and from any and all amounts paid by him or her
in satisfaction of judgment in such action, suit, or proceeding against him or her; provided he or she gives the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or
her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled pursuant to the Company’s Memorandum of Association and Articles of Association, as a
matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 

13.7    Expenses. The expenses of administering the Plan shall be borne by the Group Entities. 

13.8    Fractional Shares. No fractional Shares shall be issued and the Committee shall determine, in its
discretion, whether cash shall be given in lieu of fractional Shares or whether such fractional Shares shall be eliminated by rounding up or down as appropriate. 

13.9    Government and Other Regulations. The obligation of the Company to make payment of awards in Shares or
otherwise shall be subject to all Applicable Laws, and to such approvals by government agencies as may be required. The Company shall be under no obligation to register any of the Shares paid pursuant to the Plan under the Securities Act or any
other similar law in any applicable jurisdiction. If the Shares paid pursuant to the Plan may in certain circumstances be exempt from registration pursuant to the Securities Act or other Applicable Laws, the Company may restrict the transfer of such
Shares in such manner as it deems advisable to ensure the availability of any such exemption. 
 13.10    Governing
Law. The Plan and all Award Agreements shall be construed in accordance with and governed by the laws of the Cayman Islands. 

13.11    Section 409A. To the extent that the Committee determines that any Award granted under
the Plan is or may become subject to Section 409A of the Code, the Award Agreement evidencing such Award shall incorporate the terms and conditions required by Section 409A of the Code. To the extent applicable, the Plan and the Award
Agreements shall be interpreted in accordance with Section 409A of the Code and the U.S. Department of Treasury regulations and other interpretative guidance issued thereunder, including without limitation any such regulation or other guidance
that may be issued after the Effective Date. Notwithstanding any provision of the Plan to the contrary, in the event that following the Effective Date the Committee determines that any Award may be subject to Section 409A of the Code and
related Department of Treasury guidance (including such Department of Treasury guidance as may be issued after the Effective Date), the Committee may adopt such amendments to the Plan and the applicable Award agreement or adopt other policies and
procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Committee determines are necessary or appropriate to (a) exempt the Award from Section 409A of the Code and/or preserve
the intended tax treatment of the benefits provided with respect to the Award, or (b) comply with the requirements of Section 409A of the Code and related U.S. Department of Treasury guidance. 

  
 17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}]]